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Eukaryotic DNA is found packaged with proteins and RNA, which forms 
a substance called chromatin. This packaging is dynamic and regulates 
access to DNA for essential cellular processes such as transcription, 
replication, and repair. In recent years, studies have shown that regulated 
changes in the chemical and physical properties of chromatin often lead to 
dynamic changes in multiple cellular processes by affecting the accessibility 
of the DNA. These changes can be brought about in part through post-
translational modifications of histone proteins, which are involved in 
disrupting chromatin contacts or by recruiting effector proteins to chromatin. 
Acetylation is one of the well-studied post-translational modifications 
that has been associated with chromatin-associated processes, notably gene 
regulation. Many studies have contributed to our knowledge of the 
enzymology underlying acetylation, including efforts to understand the 
molecular mechanism of substrate recognition by several acetyltransferases, 
but traditional experiments to determine intrinsic features of substrate and 
site specificity have proven challenging. In my thesis work, I hypothesize 
that the primary amino acid sequence surrounding an acetylated lysine plays 
a critical role in acetylation site selection, and whether there are sequence 
preferences that enable a lysine acetyltransferase to recognize target 
lysines. A computational method was devised to examine this hypothesis, 
and an experimental approach was taken to test my computationally-derived 
predictions. In Chapter 2, I describe my basic computational methods, using 
a clustering analysis of protein sequences to predict lysine acetylation based 
on the sequence characteristics of acetylated lysines within histones. I define 
a local amino acid sequence composition that represents potential 
acetylation sites by implementing a clustering analysis of histone and non-
histone sequences. I demonstrate that this sequence composition has 
predictive power on two independent experimental datasets of acetylation 
marks. In Chapter 3, I describe the experimental validation approach used 
to detect acetylation in histone and nonhistone proteins using mass 
spectrometry. I also report several novel non-histone acetylated substrates 
in S. cerevisiae. My approach, combined with more traditional experimental 
methods, may be useful for identifying additional proteins in the acetylome.  
Finally, in Chapter 4, I describe two bioinformatics approaches; one to 
predict additional chromatin associated effector proteins, and another to 
further understand the evolutionary history and complexity of the Polycomb 
Group (PcG) proteins in multicellular organisms in order to infer gene 
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         Chapter 1: General Introduction  
The annotated human genome contains approximately 40,000 genes by 
current estimates (Karolchik, Baertsch et al. 2003), a number that seems 
surprisingly low.  However, the estimated number of proteins encoded by 
these genes is two to three orders of magnitude higher (Hsu, Pringle et al. 
2005).  Because each protein is generally encoded by one gene in the 
genome, one might expect a one to one correspondence of genes to 
proteins.  However, this is not the case: the estimated number of proteins 
encoded by the 40,000 human genes is two to three orders of magnitude 
higher.  What is the purpose of this diversity?  Proteome complexity can be 
built by diversification at both the mRNA level (through alternative splicing) 
and the protein level (through post-translational modification (PTM) of the 
protein side chains).  Greater than 5% of the genes in the human genome 
encode enzymes that catalyze such modifications, including hundreds of 
protein kinases, phosphatases, ubiquitiyl ligases, acetylases and 
deacetylases, methyl transferases and glycosyl transferases.  By adding 
chemical moieties onto one or more amino acids, PTMs can determine a 
protein’s localization, interactions with other proteins, and gene expression. 
For example, phosphorylation of a protein substrate can propagate 
downstream signaling events (Burnett and Kennedy 1954; Olsen, Blagoev et 
al. 2006), ubiquitination marks cyclins  and other proteins for degradation at 
cell-cycle specific time points (Xu, Duong et al. 2009), and methylation can 
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epigenetically activate (Beisel, Imhof et al. 2002) or repress gene expression 
(Nakayama, Rice et al. 2001; Grewal and Rice 2004). 
PTMs are particularly abundant and well studied in histone proteins, 
the major protein components of chromatin. Chromatin is the coupling of 
DNA, RNA, and protein that make up chromosomes.  The nucleosome, the 
fundamental repeating unit of chromatin, consists of 146 base pairs of DNA 
wrapped around the four core histones (H2A, H2B, H3, H4)(Luger, Mader et 
al. 1997) (Figures 1.1A, B).  Multiple nucleosomes joined by stretches of 
linker DNA form a structure known as “beads on a string” (Figure 1.1B).  
We are only beginning to understand that the changes in chromatin 
structure that underlie many DNA-templated processes are affected by post-
translational modification of histone proteins, including but not limited to 
methylation, phosphorylation, and acetylation (Figure 1.1C).  These 
modifications may contribute to “epigenetic signatures” that are important 
for diverse processes such as gene regulation, apoptosis, mitosis, and 
responses to DNA damage. These modifications create a dynamic readout, 
referred to as the “histone code” (Strahl and Allis 2000; Turner 2008), 
where PTMs can function as binding sites for specific protein domains while 















Figure 1.1: Chromatin organization and post-translational modifications 
A. A nucleosome particle is composed of 146 bp of DNA wrapped around an octamer of 2 
copies each of histones H2A, H2B, H3, and H4, with the tails of the histone proteins 
protruding from the core structure.  These particles are then linked together by the DNA to 
form a structure known as “beads on a string”. Image modified from (Marmorstein 2001).  
B. Crystal structure of nucleosome solved at 2.8Å. Nucleosome core particle: ribbon traces 
for the 146-bp DNA (Watson strand and Crick strands in brown and turquoise, respectively) 
and eight histone protein main chains (blue: H3; green: H4; yellow: H2A; red: H2B). Image 
adapted from (Luger, Mader et al. 1997). 
C. Shown are the four core histones: H3, H4, H2A, and H2B, and their post-translational 
modification sites. Acetylation marks are denoted by red filled circles, arginine methylation 
denoted by yellow hexagons, and lysine methylation denoted by green or red hexagons. For 
lysine methylation sites, green hexagons denote active marks (such as H3K4me) while red 
hexagons denote repressive marks, (such as H3K27). Green circles are phosphorylationa nd 
blue ovals are ubiquitylation. Boxes surrounding H3, H4, H2A, and H2B represent histone 




















Histone Acetylation  
More than forty years ago, Allfrey and colleagues reported a strong 
correlation between increased levels of histone acetylation and elevated 
levels of gene expression (Allfrey, Faulkner et al. 1964).  Since then, the 
field of chromatin biology has advanced considerably with remarkable 
progress made into mechanistic insights of histone modifications and their 
biological functions.  Histone acetylation has the capacity to destabilize the 
chromatin polymer through neutralization of the basic charge of the lysine 
residue, potentially with consequences for chromatin nucleosomal stability 
and higher-order structure (“cis” effects) (Tse, Sera et al. 1998; Verreault, 
Kaufman et al. 1998; Taverna, Li et al. 2007).  Furthermore, acetylation can 
potentially affect chromatin dynamics by recruiting specialized “effector” 
proteins (“trans”-effects) (Jenuwein and Allis 2001).  
Lysine acetylation in histones was the first PTM for which the enzymes 
that both catalyze HATs (histone acetyltransferases) and remove HDACs 
(histone deacetylases) was identified.  These enzymes are responsible for 
governing a steady-state balance of acetylation (Brownell, Zhou et al. 1996; 
Taunton, Hassig et al. 1996; Pflum, Tong et al. 2001).  In fact, the first 
transcription-related nuclear histone acetyltransferase (HAT, or KAT 
renamed in (Allis, Berger et al. 2007)), Gcn5, was isolated from the 
Tetrahymena macronucleus through an in-gel assay (a mixture of proteins 
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from cell extracts separated on a SDS gel) (Brownell, Zhou et al. 1996). 
Since then, the discovery of KAT proteins acetylating all four core histones 
has been a hallmark for the chromatin field as researchers have studied the 
individual modifications and their functional relevance in the cell (Kurdistani, 
Tavazoie et al. 2004; Shogren-Knaak, Ishii et al. 2006; Kaplan, Liu et al. 
2008; Li, Zhou et al. 2008; Tjeertes, Miller et al. 2009)(Figure 1.2A; in 
red).  In addition to the discovery of the first transcription-related histone 
KAT, the discovery of the first transcription related histone HDAC, HDAC1, 
(Taunton, Hassig et al. 1996) also led to the formation of a model for gene-
specific histone PTMs: activators that are bound by DNA are involved in 
recruiting KATs to acetylate nucleosomal histones, while repressors recruit 
HDACs to deacetylate histones.  Three years later, the first bromodomain 
was discovered as a protein that interacts specifically with acetylated lysines 
in histones (Dhalluin, Carlson et al. 1999), making it the first known protein 
module to do so. Bromodomains were functionally linked to the HAT activity 
of co-activators in the regulation of gene transcription.  Together, modifying 
enzymes that “write” the PTM, enzymes that “erase” the PTM, and molecules 
that interact specifically with the PTM or “readers”, are linked to enzyme 
activity in gene expression regulation, but how do these molecules recognize 
their epitopes, and what dictates their recognition machinery?  Primary 
sequence context surrounding a target lysine could be one major factor 
dictating these types of recognition (Figure 1.2B), however this factor is 
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still relatively understudied. Limited biochemical and structural studies of 
KATs and bromodomain coupled to histones display some sequence 
preferences (Mujtaba, Zeng et al. 2007; Liu, Wang et al. 2008), however a 
rigorous and thorough analysis is still needed to pinpoint specific sequence 
motifs or patterns on the substrate that help establish appropriate 










































Figure 1.2: Histone Acetylation Function and Primary Sequence Context   
A. Acetylation marks are denoted by red circles. Functions associated with the acetyl marks 
are shown by a rectangular box. Image modified from Epigenetics,2007.  
B. Lysine in center (red) and letters (in black) surrounding lysine represent the primary 
sequence context of a PTM.  Effector (in green) also can bind the modification based on 





























Structural analyses of KATs coupled to histone tail peptides have been 
the subject of intense study.  KAT enzymes catalyze the transfer of an acetyl 
group from the co-factor acetyl-Coenzyme A (acetyl-CoA) to the -amine of 
a substrate lysine side chain.  A large number of KATs have now been 
identified and characterized.  Studies on the divergent histone KAT enzymes 
Gcn5/PCAF, Esa1 and Hat1 have provided insights into the underlying 
mechanism of acetylation by KAT proteins (Marmorstein 2001; Marmorstein 
and Roth 2001).  These three histone KAT enzymes contain a conserved core 
domain that plays a role in binding the co-factor acetyl-CoA in catalysis. 
More recently, biochemical and structural studies of the metazoan-specific 
p300/CBP (human homolog of Gcn5) and fungal-specific Rtt109 histone 
KATs have provided a new understanding into the evolutionary and ancestral 
relationship between histone KATs and their divergent catalytic and 
substrate-binding properties (Wang, Tang et al. 2008). 
Co-crystallized histone KATs coupled to peptides also provide insight 
regarding substrate recognition.  Positively charged residues are typically 
present within three to four amino acid residues (about 10 Å) upstream or 
downstream of the acetylated lysine residues of known p300 (a human 
homolog of Gcn5)/CBP substrates (Wang, Tang et al. 2008).  Moreover, the 
X-ray crystal structure of p300, in complex with a bi-substrate inhibitor, Lys-
CoA reveals the preference for nearby basic residues, such as a lysine in the 
+2 and -2 positions (Wang, Tang et al. 2008).  Specificity for a random-coil 
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structure containing a G-K-X-P recognition sequence on the histone 
substrate is revealed the when the Gcn5 crystal structure is coupled to the 
H31-20 peptide (Rojas, Trievel et al. 1999; Liu, Wang et al. 2008) (Figure 
1.3).  Critical contacts between Gcn5 and H3K14 are displayed; the glycines 
(G13), and proline (P15) preceding and following H3 lysine 14 make the 
tightest contacts with Gcn5 and suggest residues that are specific to Gcn5 
recognition.   Other nonhistone Gcn5-mediated substrates also possess a 
similar G-K-X-P pattern and will be described further in Chapter 3.  These 
studies demonstrate that residues in the core domain of the KAT together 
with proximal residues surrounding acetyl-lysines on the histone substrate 
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Figure 1.3: Gcn5 (a histone KAT) coupled to histone H3 peptide and coenzyme A 
(CoA) 
Solvent accessible surface representation of Tetrahymena GCN5 HAT domain coupled to 
Histone H31-20 peptide (in yellow) and CoA (shown clearer in enlarged box; bottom). Red 
box (bottom) represents an enlarged view of the Gcn5 HAT domain in contact with the 
H3S10-P16 residues of the peptide represented by a stick model. CoA is shown on bottom 
right. Note that G12 and P16 make direct contacts with the catalytic domain. Image 






Nonhistone protein acetylation and methods in detecting acetylated 
substrates   
To a lesser extent, nonhistone protein acetylation has also been implicated 
in a wide variety of biological processes, such as DNA binding or the 
stabilization of multi-subunit complexes (Glozak, Sengupta et al. 2005) 
(Sterner and Berger 2000; Yang and Seto 2008).  One of the most famous 
nonhistone proteins that was discovered as acetylated was p53, where 
pioneering studies by Roeder and colleagues demonstrated that p53 
acetylation was critical for the regulation of its binding to the DNA (Figure 
1.4A,B) (Gu and Roeder 1997).  Since then, KATs, such as p300, have been 
shown to acetylate multiple other nonhistone transcription-related proteins. 
Additional studies have identified additional acetylated proteins, such as 
HIV1 integrase (Cereseto, Manganaro et al. 2005), an HIV protein whose 
acetylation is required for its viral integration.  Acetylation of alpha tubulin 
was also recently shown to be critical for the formation of cortical neurons in 
the developing mouse brain (Wynshaw-Boris 2009).  Intriguingly, several 
transcription factors, such as E2F1, and MYC implicated in cancer pathways, 
have also been shown to be acetylated (Sterner and Berger 2000; Ozaki, 
Okoshi et al. 2009).  
Conventional experiments, such as mutagenesis of potential acetylated 
lysines, acetylation-specific antibodies, metabolic labeling, mass 
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spectrometry (MS), and in-vitro histone acetyltransferase assays (Figure 
1.4C) have typically been used in order to identify acetylated lysines in 
substrate proteins. More recently, large scale proteomic studies have 
emerged as a result of high- throughput technology.  In one study, the KAT 
NuA4 (the essential nucleosome acetyltransferase of H4) was incubated with 
yeast proteome microarrays in the presence of radioactive acetyl-CoA.  Many 
non-chromatin substrates of complex were identified and validated, including 
acetylation (Lys19 and Lys514) of phosphoenolpyruvate carboxykinase 
(Pck1p).  Acetylation at these sites was then shown to be important for 
yeast glucogenesis (Lin, Lu et al. 2009). Additionally, advanced proteomic 
tools have enabled identification of several hundred acetylation sites in 
approximately two hundred proteins, using samples derived from HeLa cells, 
mouse liver and bacteria (Kim, Sprung et al. 2006). In addition to regulators 
of chromatin-based cellular processes, non-nuclear proteins with diverse 
functions were also identified.  Most strikingly, acetylated lysines were found 
in more than 20% of mitochondrial proteins, including many metabolic 
enzymes (Kim, Sprung et al. 2006). Another high resolution mass 
spectrometry study published recently revealed that lysine acetylation 
preferentially targets large macromolecular complexes involved in diverse 
cellular processes, such as chromatin remodeling, cell cycle, splicing, nuclear 
transport, and actin nucleation.  The study also reveals that acetylation 
substrates had enriched residues flanking the target lysine depending on 
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whether the protein resided in the nuclear, cytoplasm, or mitochondria 













































Figure 1.4: Examples of nonhistone protein acetylation  
A. p53 was one of the first nonhistone acetylated proteins discovered via radioactive 
labeling (Gu and Roeder 1997). The protein (total of 393 amino acids) is heavily acetylated 
protein in the C-terminal tail. Eight lysines have have been identified as acetylated via mass 
spectrometry, immunoblotting, and mutagenesis experiments. p53 acetylation stimulates 
sequence specific DNA binding activity in vivo and in vitro and increases stability of protein.  
B. A histone KAT can also acetylate lysines in nonhistone proteins. p53 is a classic example, 
where p300 ( the histone KAT) acetylates multiple residues of p53 as shown in B, but also 
lysines in the core histones.  
C. Some of the traditional methods used to identify PTMs on histone and nonhistone 
proteins.  Shown are biochemistry methods, metabolic labeling, site-directed mutagenesis 























Thus, the discovery of acetylation on histone and nonhistone proteins 
has been a key advancement in the chromatin field, and has allowed for a 
better understanding of the roles acetylation plays in human biology and 
disease.  Promising advances have been made in the treatment of certain 
cancers by developing drug therapies that target HDACs (Marks 2007).  
While knowing which amino acids in the proteome are acetylated has clear 
biological and disease applications, currently, only a subset of the total 
acetylated residues in the proteome have been identified.  Methods that 
allow for rapid identification of all acetylated amino acids in the proteome 
would therefore be of great importance to the biological community.  A 
computational tool that is predictive of acetylation events in histone and 
nonhistones could contribute to a more complete understanding of what 
substrates are physiologically relevant, as more insights are gained into 
acetylation-mediated pathways.   
Computational studies  
A limited number of studies suggest that there may be sequence recognition 
target(s) for certain KATs (Kimura and Horikoshi 1998; Kimura and 
Horikoshi 1998).  A putative “rule” for lysine selection in a primary sequence 
by a KAT has been proposed previously by examining the N-terminal tail of 
histones (Kimura and Horikoshi 1998).  For example, TIP60 (a mammalian 
KAT), recognizes specific glycine-lysine G-K patterns in human proteins in 
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vitro and in vivo (Kimura and Horikoshi 1998).  Additionally, the acetylation 
of Rch1 (a nuclear importin factor) is severely inhibited when a glycine 
adjacent to the modified lysine is mutated, supporting the view that G-K is 
part of a recognition motif for acetylation (Bannister, Miska et al. 2000).  
Moreover, the KAT CLOCK1, acetylates H3 lysine 14, which bears a similar 
sequence environment to the acetylated lysine of the CLOCK-mediated 
substrate BMAL1 (Hirayama, Sahar et al. 2007).  The term “histone mimic” 
was recently put forward to describe short stretches in nonhistone proteins 
that closely resemble histone sequences containing PTMs (Sampath, Marazzi 
et al. 2007).  Observations such as these provide early indications of specific 
“rules” that can potentially define enzyme recognition of target substrates.  
More recently, a prediction program was published illustrating that 
acetylation could be predicted via an analysis of lysine acetylation motifs in a 
large human proteome-wide dataset (Schwartz, Chou et al. 2009).  These 
motifs were scanned against proteomic sequence data using a newly 
developed tool called scan-x to globally predict other potential modification 
sites within multiple organisms.  Ten-fold cross-validation was used to 
determine the sensitivity and minimum specificity for each set of predictions, 
where a specificity (proportion of of actual positives which are correctly 
identified) 94%, and a sensitivity (proportion of negatives which are 
correctly identified) of 17% was achieved.  In Chapter 2, I describe a 
computational model which I have developed to predict human additional 
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histone and nonhistone substrates in the acetylome.  In addition to a 
computational approach, I experimentally validated my target predictions in 
budding yeast in vivo as described in Chapter 3.   
Yeast PTMs and conservation of histones 
Histones are among the most highly conserved proteins across species, 
allowing for their study in multiple organisms. In particular, acetylation in 
budding yeast histones is a well-studied phenomenon. Extensive studies 
mapping acetylation and the responsible enzymatic pathways using the 
yeast core histones have been performed (Grunstein 1990; Clarke, O'Neill et 
al. 1993; Brownell, Zhou et al. 1996; Grant, Duggan et al. 1997; Smith, 
Eisen et al. 1998; Bird, Yu et al. 2002).  These studies were possible through 
traditional biochemical methods (Figure 1.4C) and highly specific antibodies 
against histone acetyl-lysines that have been widely used in yeast chromatin 
studies (Suka, Suka et al. 2001).  Genome wide mapping studies of yeast 
acetylation (via ChIP-Chip) illustrate that H3K9ac peaks at the predicted 
transcriptional start sites of active genes and that this modification 
correlates with transcription rates genome-wide (Figure 1.5A) (Pokholok, 
Harbison et al. 2005).  Similarly, acetylation of histone H3 at lysine 14 peaks 
over the start sites of active genes and correlates with transcription rates 
genome-wide.   Additionally, H3K36 was discovered as acetylated (Figure 
1.5A) and the pattern of H3K36ac localization is similar to that of other sites 
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of H3 acetylation, including H3K9ac and H3K14ac, although the peak of 
H3K36me2, a well described PTM in yeast, is within the active gene coding 
region (Figure 1.5A) (Morris, Rao et al. 2007).  Set2 (KMT3)-dependent 
methylation of histone H3 at lysine 36 (H3K36) was also shown to promote 
deacetylation and repression (Youdell, Kizer et al. 2008).  
Perhaps one of the better described and major acetylation marks in 
budding yeast is H3K56, an acetylation mark in the globular domain of H3, 
which is critical for the recruitment of the nucleosome remodeling factor 
Snf5 and subsequent transcription (Xu, Zhang et al. 2005).  These findings 
indicated to the chromatin field that histone H3 K56 acetylation enables 
recruitment of the SWI/SNF nucleosome remodeling complex to regulate 
gene activity.  Moreover, H3K56ac has been shown as a DNA-damage-
responsive mark, important for genomic stability in mammals (Yuan, Pu et 
al. 2009).  In addition, acetylation of H3K56 is increased in multiple types of 
cancer, correlating with increased levels of ASF1A, a key protein in 
nucleosome assembly (Tjeertes, Miller et al. 2009; Yuan, Pu et al. 2009).  A 
former postdoc in the Allis Lab, Sandra Hake, along with the Don Hunt 
laboratory at UVA (Charlottesville, VA), performed an in-depth analysis of 
methylation and acetylation profiles of multiple organisms ranging from 
Tetrahymena to mammals (Figure 1.5B).  Their work illustrates that higher 
eukaryotes (multicellular) contain a higher number of methylation or 
silencing marks, whereas lower eukaryotes possess more acetylation or 
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activation marks (Garcia, Hake et al. 2007).  Moreover, within the histone 
globular domain, PTMs were far less conserved from unicellular to 
multicellular organisms (ie. K56ac), whereas the H3 tail acetylation marks 
were  more conserved between the two groups (Figure 1.5B) (Garcia, Hake 











































Figure 1.5: H3 acetylation in yeast and conservation between organisms 
A. ChIP study showing that H3K9/K14ac and H3K36ac (black and red curves, respectively) 
both peak at transcriptional start sites, whereas K36me2 (blue curve) peaks within active 
coding regions.  Image modified and chart lines were superimposed due to low figure 
quality from (Morris, Rao et al. 2007). 
B. Histone H3 modifications detected in MS/MS experiments from human, mouse, 
Tetrahymena, and yeast.  Acetyl marks are denoted by red circles, and methyl marks are 
denoted by green hexagons. Note that histone PTMS in tail region are more conserved in 
multicellular species and PTMs in globular region are more conserved in unicellular species. 



















Mutagenesis and crosstalk experiments in yeast 
Since yeast is easy to genetically manipulate, many labs including ours have 
used it for mutagenesis and functional studies of post-translational 
modifications of histones.  Groups such as the Michael Grunstein lab have 
performed tail deletions of H2A and H2B and swapping experiments of the 
H3 and H4 tails in yeast, which resulted in the disrupted regulation of 
specific genes as well as silencing of yeast mating type cassettes (Schuster, 
Han et al. 1986; Ling, Harkness et al. 1996).  More recently, the Shilatifard 
group systematically generated a complete library of the alanine 
substitutions of all of the residues of the four core histones in S. cerevisiae 
(Nakanishi, Sanderson et al. 2008).  Several cases where one mark was 
required for another on the histone H3 N-terminal tail were identified, 
including histone H3K14ac (H3K14ac), a mark which is required for normal 
levels of H3K4 trimethylation (Nakanishi, Sanderson et al. 2008).  Additional 
data on crosstalk, or one mark is required for the presence or absence of 
another mark of covalent modifications of histones in yeast reveal that 
phosphorylation of serine 10 in histone H3 is functionally linked in vitro and 
in vivo to Gcn5-mediated acetylation at H3K14 (Lo, Trievel et al. 2000). 
These types of observations suggest that transcriptional regulation can occur 
through multiple linked covalent modifications in histones (Lo, Trievel et al. 
2000; Strahl and Allis 2000; Latham and Dent 2007) (Figure 1.6A).  
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The Boeke laboratory recently created a versatile library of 486 
systematic histone H3 and H4 substitution and deletion mutants that probes 
the contribution of each residue to nucleosome function.  Their findings 
suggest that there are surprisingly a few residues essential for cell viability 
considering the very well conserved sequences of H3 and H4 among 
different organisms.  This observation implies a possibility that multiple 
residues on histones can function redundantly (Dai, Hyland et al. 2008).  
Typically, in order to detect phenotypes and analyze how PTMs can cross-
regulate one another (as described in the previous section), lysines which 
are positively charged, acetylable residues, are mutated to small (uncharged 
residues such as alanine or glycine), arginines (positively charged, and 
unacetylable), or glutamines (negatively charged, acetyl mimics) (Figure 
1.6B).  Single lysine mutations have demonstrated phenotypic defects in 
yeast, such as H3K36R producing a transcriptional elongation defect 
(Carrozza, Li et al. 2005), H3K56R producing genome stability defects, 
chromosomal breaks, and cell lifespan reduction (Recht, Tsubota et al. 2006; 
Driscoll, Hudson et al. 2007; Dang, Steffen et al. 2009), and H4K16Q 
significantly reducing cell lifespan (Dang, Steffen et al. 2009). Multiple 
mutations on identical or different histones have also demonstrated 
phenotypes, such as  H3K56R combined with H4K5,8,12R for replication (Li, 
Zhou et al. 2008), and H4K5,8,12,16R for cell viability (Megee, Morgan et al. 
1990).  While larger mutagenesis studies and screens have focused on 
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designing experiments to abrogate levels of specific PTM marks, only a few 
studies to my knowledge have been aimed at mutating the surrounding 
residues of the target lysine to detect a different PTM than was previously 
known, or to observe an increase or decrease of the PTM level of the target 
lysine (Bannister, Miska et al. 2000; Nelson, Santos-Rosa et al. 2006).  In 
my own work described in Chapter 3, I have mutagenized the flanking 
residues of H3K14 to in order to determine whether the mutation of its 
flanking residues has any effect on H3K14ac levels, or whether mutagenesis 


































Figure 1.6:  Crosstalk between lysine methylation and acetylation on H3 and H4 
histone tails. 
A. Crosstalk between H3K9, H3S10, and H3K14 based on previous literature. The H3 
modifications also have an effect on H4K20 methylation (top). H3ac/H4ac crosstalk with 
H3K4me (bottom). H3ac/H4ac refer to multiple acetylation sites on H3 and H4. Red circles 
represent acetylation marks, green hexagons represent methylation marks, and white 
circles represent phosphorylation marks. Image adapted from (Latham and Dent 2007)   
B. Lysines (positively charged, acetylable residues) typically mutated into small uncharged 
residues (glycine or alanine), charged, unacetylable residues (arginine), and uncharged, 
acetyl mimics (glutamines) for phenotypic analysis, PTM detection, or to detect effects on 














In the previous sections, I discussed protein acetylation, focused largely on 
histone acetylation “writers”.  In the next section, I will next discuss 
“readers,” proteins that interact specifically with a PTM and the historic 
challenges and methods used to uncover additional domains within these 
readers.  I will also briefly introduce the domain structure and functional 
importance of an array of chromatin-associated proteins. 
Domain Prediction Challenges   
Domain prediction from primary amino acid sequence has historically been a 
challenging task.  However, improved domain prediction programs are 
enabling high accuracy structure predictions, more directed mutagenesis and 
binding studies, and a deeper scope to perform evolutionary analyses.  Many 
protein motifs characteristically associated with chromatin have been shown 
to have affinity for modified histone tails, acting as “effectors” or readers for 
histone PTMs, notably lysine acetylation and methylation.  These motifs have 
been discovered through experimental cloning and in-vitro peptide binding 
assays, however since there are multiple modifications on the protein with a 
multitude of interaction partners, a number of these effector molecules have 
yet to be discovered.   Using domain prediction tools and computational 
techniques can thus help us achieve a higher number of chromatin binding 
domains that are still undiscovered.   In Chapter 4, I aim to describe the 
bioinformatic method I used to predict additional effectors in chromatin 
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associated proteins, and present data on the evolutionary domain analysis of 
PcG proteins.  
Domain definitions and statistical methods used to characterize 
domains 
To understand the roots of the domain prediction challenge, one needs to 
delve deeply into the definition of a domain.  Domains are considered to be 
the building units of protein structure.  A protein can contain a single domain 
or multiple domains, each one typically associated with a specific function. 
The architecture of a protein’s domain determines the function of the 
protein, its subcellular localization and the intermolecular interactions it is 
involved in.  However, over the years, domains have been defined in several 
different ways, each definition focusing on a different aspect of the domain 
hypothesis (Ingolfsson and Yona 2008): 
-A domain is a protein unit that can fold independently 
-It forms a specific fold in 3D space  
-It performs a specific task/function 
-It is a movable unit that was formed early on in the course of evolution 
 
Most of these definitions are widely accepted, but some are more 
subjective than others.  For example, the definition of a cluster in 3D space 
is dependent on the algorithm and experimental data used to define the 
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clusters and the parameters of that algorithm.  Furthermore, while the first 
two definitions focus on structural aspects, the other definitions do not 
necessarily contain a structural constraint.  Domain prediction programs 
such as SMART and PFAM (Schultz, Milpetz et al. 1998; Finn, Tate et al. 
2008) have aimed to overcome these challenges by using statistical 
prediction methods.  However because the precise definition of domain is 
subjective, predicted domains can be missed in these programs largely for a 
number of reasons:  (1) The protein of interest might contain new domains 
that have not been characterized or studied yet, and therefore the protein 
might be poorly represented in existing domain databases with limited 
information about its domain.  For most proteins (and especially newly 
sequenced ones) the structure is unknown, thus structure-focused methods 
are excluded. (2) Protein should have homologs in order for the prediction 
method to be effective.  Methods may only work using databases of proteins 
containing homology, but not on individual proteins. (3) Existing domain 
prediction algorithms can be inconsistent in their domain annotations.  
Without accurate structural information, it is difficult to validate the 
performance of prediction algorithms.  When the structure is known, 
determining the constituent domains might not be straightforward 
(Ingolfsson and Yona 2008).  
Statistical prediction methods have tried to solve the multifaceted 
problem of domain prediction by implementing well-constructed multiple 
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sequence alignments (MSAs), which are a positive source of information for 
domain predictions.  These MSAs feed into a statistical model, typically a 
Hidden Markov Model (HMM), which computes the probability of a given 
sequence by using the consensus MSA to predict additional domains of 
interest.  MSA alignments are much easier and faster to generate than 
three-dimensional models and can thus be used in large-scale domain 
predictions.  Moreover, MSAs can also be used to detect remote homologies.  
On the other hand, sequences that are highly similar usually contain little 
information on domain boundaries and bias predictions as they mask other 
equally crucial but less represented sequences.  
Several atypical or cryptic domains, domains which are dissimilar to 
the canonical domain by sequence, yet contain some or all the key residues 
are typically needed for the binding surface are often missed by domain 
prediction programs.  These types of domains are challenging for prediction 
algorithms since domains often function through intermolecular interactions 
that depend on chemical and structural properties of the interacting surface 
that need to be compensated for, and primary amino acid sequence is 
insufficient.  RAG2 (an essential component of the RAG1/2 V(D)J 
recombinase) is an example of a protein that contains a plant homeodomain 
(PHD) finger that specifically recognizes histone H3 trimethylated at lysine 4 
(H3K4me3) (Matthews, Kuo et al. 2007).  Though RAG2 has a conserved 
tryptophan that constitutes a key structural component of the K4me3-
33 
 
binding surface and is essential for Rag2's recognition of H3K4me3, the 
overall similarity of RAG2’s PHD finger with the canonical domain is only 
25% similar by amino acid sequence and therefore is missed by domain 
prediction programs.  These examples display that with a better training set, 
and manipulation of key sequence parameters, we can improve reliability 
and the number of predictions generated on single and multidomain 
proteins.  
  While many of the proteins known today contain a single domain, it 
has been noted that the majority of proteins contain multiple domains. 
Consistent with the evolutionary aspect of the domain hypothesis, more 
complex organisms have a higher number of multi-domain proteins (Tordai, 
Nagy et al. 2005).  Multidomain proteins represent a substantial fraction of 
the proteome: about 27% of proteins in bacteria and 39% of proteins in 
metazoa are multi-domain proteins (Tordai, Nagy et al. 2005).  Multidomain 
proteins are structurally (and often functionally) more complex than single-
domain proteins, which lends itself to additional complexity at the protein 
signaling level.   Multidomains proteins can evolve through gene duplication 
and domain shuffling (insertion, deletion, rearrangement, and internal 
duplication of domains), which can be caused by duplication and insertion of 
a domain into a novel genomic context, tandem duplication of domains, 




Chromatin associated domains and importance 
A great deal of evidence suggests that PTMs function through the 
recruitment of downstream effector proteins, which in turn perform a task  
on chromatin (Shi, Hong et al. 2006) (Wysocka, Swigut et al. 2006) (Figure 
1.7A).  A specific role for post-translational modifications on histones 
(histone marks) is to stabilize the binding of effector proteins, which can 
influence gene expression by modifying chromatin structure, recruiting the 
components of the transcription machinery, or establish additional 


































Figure 1.7: Effector proteins and cryptic domains 
A. Well characterized bromodomain (BD), chromodomain (CD), and PHD finger domains in 
histones H3 and H4. Shown is the Drosophila NURF 301 PHD finger bound to H3K4me3, HP1 
chromodomain bound to H3K9me, Polycomb (Pc) bound to H3K27me, and the bromodomain 
of GCN5 bound to H4K16 in yeast.  
B. Multiple sequence alignment of ING2 PHD fingers. Aromatic cage residues, zinc 
coordination residues, and histone H3 arginine 2-interacting residues are colored in purple, 
red, and orange, respectively. Mouse RAG2 is highlighted (in red box) and displays a cryptic 
PHD finger due to the sequence dissimilarity with coordinated Zn and cage residues. Image 




















Wysocka et al. show that a plant homeodomain (PHD) finger of nucleosome 
remodeling factor (NURF), an ISWI-containing ATP-dependent chromatin-
remodeling complex, interacts with H3K4me3.  When the PHD finger is 
deleted in Xenopus, a loss-of-function phenotype is observed, and 
compromises spatial control of Hox gene expression (Wysocka, Swigut et al. 
2006).  Additional PHD finger proteins have more recently been shown to be 
implicated in disease, such as MLL (Wang, Song et al. 2009), RAG2 
(Matthews, Kuo et al. 2007) (Figure 1.7B; red box), and Kap1 (Zeng, Yap 
et al. 2008).  Crystal studies of the numerous PHD finger domains coupled to 
H3 peptides have revealed high conservation within the domain and an 
aromatic cage that is important for histone binding selectivity for H3K4me3. 
Moreover, crystal structures of the BPTF PHD finger coupled to the H3 
peptide display that the residues in the N-2 and N+2 positions respective to 
the H3K4 mark, are often critical determinants of binding specificity 
(Taverna, Li et al. 2007).  
Another domain of interest is the bromodomain which recognizes 
acetylated lysine residues such as those on the N-terminal tails of histones. 
Bromodomain binding perpetrates a pivotal mechanism for regulating 
protein-protein interactions in histone-directed chromatin remodeling and 
gene transcription (Figure 1.7A) (Mujtaba, Zeng et al. 2007).  Several 
reports indicate that the overall fold of bromodomains is highly conserved, 
but the subtle structure of the non-conserved loop region is crucial to their 
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function (Mujtaba, Zeng et al. 2007).  The chromodomain which recognizes 
methyl-lysines (the most famous being HP1 which binds to H3K9me (Figure 
1.7A) is part of the Royal Superfamily of protein folds, which also includes 
the Tudor, Chromo barrel, and MBT domains (Taverna, Li et al. 2007).  The 
HP1 and Polycomb chromodomains, which are similar to the chromodomains 
of CDY family proteins, distinguish two methylated lysine residues within 
ARKS motifs in the H3 tail (H3K9me and H3K27me) (Figure 1.8A; boxed in 
red).   
While the Polycomb “readers” and “writers” are fairly well understood 
in Drosophila (Figure 1.8A), in higher organisms, the specificity of effector 
interaction, such as chromodomain recognition becomes murky and less 
understood.  In particular, the Chromobox (Cbx) chromodomain-containing 
proteins underwent a massive expansion in mammals, with a total of five 
Cbx paralogs compared to one protein in Drosophila, known as Pc.  It has 
been shown that not all chromodomains (CDs) within the Cbx family of 
highly conserved chromodomains within the Polycomb family display affinity 
towards both histone H3 trimethylated at K9 and H3K27 (Bernstein, Duncan 
et al. 2006).  Some display preferential affinity towards histone H3K9me3 
and some towards H3K27me3.  While H3K9 and H3K27 are identical in 
surrounding sequence profile, the distinct functions of these marks is 
intriguing.  It has been suggested that residues immediately preceding the 
ARK(S/T) motif impact on the specificity of chromodomain interactions 
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(Fischle, Wang et al. 2003).  Amino acids proximal to the substrates, or 
motifs on the effectors outside of key conserved domains could be 
contributing to the specificity of these interactions (Fischle, Wang et al. 
2003).  Thus, in order to detect additional unannotated domains, and motifs 
in these complex proteins, a bioinformatics sequence based method and 
phylogenetics approach is useful to gain insight about these set of highly 
conserved, yet functionally divergent proteins.  In Chapter 4, I discuss the 
domain finding method I performed to detect additional unannotated 
domains within the PcG family of proteins in multiple organisms in order to 
infer gene expansion and diversification.  In the remainder of this chapter, I 
briefly introduce PcG complexes and their core functions.  
PcG complexes and their evolutionary history  
The PcG proteins are structurally and functionally diverse and form large 
multimeric complexes of two general types: Polycomb repressive complex 1 
(PRC1) and PRC2 (Ringrose and Paro 2004) (Figure 1.8B).  These 
complexes post-translationally modify histone tails and are believed to 
cooperate in transcriptional repression of target genes by altering local, 
higher-order chromatin structure (Francis, Kingston et al. 2004; Sparmann 
and van Lohuizen 2006).  
Polycomb group complexes, which are known to regulate homeotic 
genes, have now been found to control hundreds of other genes in mammals 
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and insects.  Polycomb complexes function as global enforcers of 
epigenetically repressed states, balanced by an antagonistic state that is 
mediated by Trithorax.  These epigenetic states must be reprogrammed 
when cells become committed to differentiation.  PcG proteins were 
originally identified in Drosophila melanogaster as factors necessary to 
maintain cell-fate decisions throughout embryogenesis by repressing Hox 
genes in a body-segment-specific manner (Kennison 1995).  Now recognized 
as a large family of chromatin-associated proteins conserved from plants to 
humans, the PcG is involved in many cellular memory processes including 
body patterning X inactivation in female mammals (Heard 2004) and 
vernalization in plants (Sung and Amasino 2004). 
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Core PRC1 is composed of Polycomb (Pc), dRing, Posterior sex combs 
(Psc) and Polyhomeotic (Ph) (Figure 1.8B) (Ringrose and Paro 2004). 
Already annotated, Pc has an N-terminal chromodomain (CD) and a C-
terminal Pc box CDs, which are found in many chromatin-associated proteins 
and are well-characterized methyllysine-binding modules (Eissenberg 2001). 
Specifically, the CD of Drosophila Pc binds most strongly to H3K27me3, the 
modification generated by PRC2 (Fischle, Wang et al. 2003).  The Pc box is a 
15-amino acid motif necessary for transcriptional repression of target 
genes and for interaction with dRing, the catalytically active subunit of PRC1 
(Muller 1995).  dRing, named for its RING-type zinc finger (Figure 1.8B), is 
an E3 ubiquitin ligase that monoubiquitylates histone H2A at lysine 119 
(H2AK119ub) (Wang, Wang et al. 2004).  This modification, along with 
H3K27me3, is important for PcG-mediated gene repression (de Napoles, 
Mermoud et al. 2004; Wang, Wang et al. 2004). The precise function of Ph 
in PRC1 complexes remains to be characterized, but it has been speculated 
that Ph might influence the spreading of PcG complexes (Kim, Gingery et al. 
2002). Additional new plant studies display significant evidence of sequence 
similarity between the C-terminal region of the PRC1 Ring finger proteins 
and the ubiquitin (Ubq)-like family of proteins, thus defining a new Ubq-like 
domain, the RAWUL domain.  Analysis of the conserved domain architecture 
among PRC1 Ring finger proteins revealed the existence of long sought PRC1 
protein orthologs in these organisms, suggesting the functional conservation 
of PRC1 throughout higher eukaryotes  (Sanchez-Pulido, Devos et al. 2008). 
Additionally, these proteins have multiple domains and not all have been 
annotated in the protein databases. Thus, being able to detect these 
domains through bioinformatic methods can potentially help us identify the 
distinct roles of PcG proteins and their cooperative mechanisms.  The Cavalli 
lab bioinformatically performed a phylogenetics analysis of PcG proteins on a 
broad spectrum of eukaryotes, and Hox gene clusters were mapped onto the 
species.  Phenotypes of PcG mutants and the strong binding of PRC1 to Hox 
gene clusters in flies and vertebrates suggested that these clusters are 
important PRC1 targets.  Thus, one hypothesis might be that PRC1 genes 
can be lost as a consequence of the disintegration of the Hox gene cluster, 
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which occurred repeatedly during evolution (Schuettengruber, Chourrout et 
al. 2007).  In Chapter 4, I will describe my aim to address the evolutionary 













































Figure 1.8: Polycomb schematic representations.  
A. Schematic representation of the H3 N-terminal tail. Shown are Drosophila proteins with 
rectangles representing the “writer” enzymes, and half moons representing effector “reader” 
molecules. The “ARKS” motif is boxed in red. Note although the ARKS sequence motif is 
identical in the two H3 positions (9 and 27), a different set of readers and writers exist for 
these two lysines. Note the gene “ON” and “OFF” mechanisms associated with the specific 
methylation marks.  
B. Schematic representation of known core members of PRC1 and PRC2 complexes. 
Drosophila proteins are shown as colored ovals; mouse homologs of these proteins are 
listed adjacently. Gray boxes denote the mammalian homologs discussed in detail 

















Chapter 2: Computational Prediction of Acetylation Substrates 
Summary 
Acetylation is a well-studied post-translational modification that has been 
associated with a broad spectrum of biological processes, notably gene 
regulation. Many studies have contributed to  knowledge of the enzymology 
underlying acetylation, including efforts to understand the molecular 
mechanism of substrate recognition by several acetyltransferases, but 
traditional experiments to determine intrinsic features of substrate site 
specificity have proven challenging.  In this project, in collaboration with Dr. 
Eran Segal at The Weizmann Institute of Science (Rehovot, Israel), I 
performed a clustering analysis of protein sequences to predict protein 
acetylation based on the sequence characteristics of acetylated lysines 
within histones.  I utilized the local amino acid sequence composition that 
represents potential acetylation sites by implementing a clustering analysis 
of histone and nonhistone sequences.  I demonstrated that this sequence 
composition has predictive power on two independent experimental datasets 
of acetylation marks.  Finally, I detected acetylation for selected putative 
substrates using mass spectrometry as described Chapter 3, and report 
several novel nonhistone acetylated substrates in budding yeast.  My 
approach, combined with more traditional experimental methods, may be 
useful for identifying acetylated substrates proteome-wide.  In this chapter,  
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I adapted text from the publication (Basu, Rose et al. 2009). 
Results 
Training, key assumptions, and method 
I used histones as a training set because of the wealth of information known 
about their PTM patterns and well-developed purification and analytical 
detection methods and focused on the major human core histones bearing a 
total of 56 lysines (H2A: 13, H2B: 19, H3: 13, H4: 11) (Figure 2.1A). To 
date, MS and antibody data suggest that there are 23 “validated” acetylated 
lysines and 33 lysines that have “not yet been observed as acetylated” in 
human histones based on literature (see Appendix for table).  I sought to 
uncover additional acetylation sites within the “not observed” class of lysines 
in a systematic, rigorous manner via my computational method.  I selected 
parameters that could influence my ability to predict acetylation sites on 
histones by making a series of assumptions.  First, I focused my attention on 
short stretches of amino acids N- and C-terminal of all 56 lysines.  Since 
structural studies of published KAT domains coupled with peptide substrates 
typically do not exceed 14-20 amino acids in length (Marmorstein 2001), a 
sliding window of a maximum number of 12 residues flanking each lysine 
was chosen (Figure 2.1B).  Residues most proximal to the lysine were 
given the highest weight (Figure 2.1B), assuming that these residues are 
most important for enzyme recognition, as several studies have shown 
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(Marmorstein 2001; Marmorstein and Roth 2001). The weight function and 
additional details on how I weighted residues is described in the Appendix. 
Second, I varied standard Blast sequence alignment parameters including 
gap penalty, extension, insertion, and deletion scores (Figure 2.1C). For 
lysines in the extreme N- and C-terminal region, such as H3K4 or H2AK129, 
I normalized the raw alignment score based on the length of the sequence.  
Additionally, both orientations of the protein sequence (N-terminal to C-
terminal or vice versa) were weighted equally.  For sequences with lysines 
located in close proximity to each other, such as H3K36 and H3K37, I 
restricted the alignment matrix so that these sequences did not receive an 
alignment score.  This restriction prevented my training set to be 
overrepresented with sequences from overlapping fragments of the same 
protein. Finally, I compensated for structural accessibility by penalizing 
buried lysines, while improving the score of accessible lysines (Luger, Mader 
et al. 1997). This, however, did not influence my ability to predict 














Figure 2.1: Schematic of computational approach 
A. Human core histone proteins (H2A: orange, H2B: red, H3: blue, H4: green) containing 
56 lysines (black) were taken as input data for computational training.  
B. A sliding window of amino acids (black bars) flanking the input lysine (at position 0) is 
used to train the model. Not all window lengths are shown. Weights (calculated as inversely 
proportional to distance [d]) are applied to amino acids based on the distance from the 
input lysine to the amino acid in positions -12 to +12.  
C. BLAST sequence alignments are performed between all 56 lysines and surrounding 
sequences and the highest scoring alignment is selected to begin the clustering analysis. 
Shown are sequences H4K5 and H3K36 (boxed in red) spanning positions -6 to +6 and their 
highest scoring match (denoted by a checkmark). Note that H4K5 and H2AK5 do not have 
six residues flanking the lysine N-terminally; scores are normalized based on length in these 
cases.  
D. Lysines clustered together based on sequence alignment scores creating a fully predictive 
hierarchical tree (four sequences are shown here; all 56 sequences are shown in Fig. 2.2). 
 E. Sequences are color coded according to published data on their modification state. Red: 
“validated” evidence of the lysine being acetylated, green: this lysine was “not observed” as 
being acetylated in literature.  
F. After establishing PredMod, predictions were made on lysines in human core histones. 
The algorithm was then validated using a set of human acetylated proteins reported in 
literature, substrates detected using a pan-acetyl IP approach, and a yeast proteome-wide 















I performed a hierarchical clustering of core histone lysines based on 
the sequences surrounding each of these given lysines.  All 56 histone core 
sequences were aligned to each other creating a matrix of pairwise 
alignment scores; generating a hierarchical tree of histone sequences 
(Figure 2.1D).  I next classified each lysine into one of two categories 
based on its acetylation status reported in literature: “validated” (23 
lysines), or “not observed” (33 lysines) (see Appendix).  Finally, I visually 
categorized each of the 56 lysines by color-coding my tree based on the 
acetylation status of each lysine (Figure 2.1E).  
To assess how robust the clustering was and how well it could actually 
predict lysine acetylation (Figure 2.1F1), I took all 56 lysines and 
performed a Leave One out cross-Validation (LOV) (Cooper, Aliferis et al. 
1997) by iteratively excluding one lysine from my training set.  Next, I 
reconstructed the hierarchical tree with the remaining 55 lysines, and 
incorporated the excluded single lysine observation as test data.  For each 
set and combination of predefined parameters (stated above) and in a single 
run, I performed a LOV analysis to examine the predictive power on all 56 
lysines to discover which set of parameters best optimized classification 
power.  If two lysines were in overlapping fragments of the same protein, I 
excluded both of these lysines from my training set when either lysine was a 
test case.  I took each test lysine (56) and traversed through my training 
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tree to find which subgroup of sequences my target sequence formed the 
tightest cluster with. 
A Receiving Operating Curve (ROC) analysis was performed on my test 
dataset (Figure 2.2), where the statistics measure used was the Area Under 
Curve (AUC).  An AUC of 1 represents a perfect prediction and an AUC of 0.5 
random predictions.  Each point on a single curve of the ROC plot was 
calculated by measuring the false positive versus true positive rate of the 
performance on all 56 lysines for a given parameter(s) under a cutoff 
alignment score.  If the “test lysine” clustered within a group of “validated” 
acetylated lysines (Figure 2.3; red color) above the cutoff score, the lysine 
was predicted to be acetylated.  Conversely, if the test lysine clustered 
within a group of “not observed” lysines (Figure 2.3; green color) above the 
alignment score, the lysine was predicted as not acetylated.  The default 
status of the lysine when it did not fall into the above criteria was “not 
acetylated.”  The best ROC plot achieved an AUC of 0.80, and the 
parameters in this case included six weighted residues to both the left and 
right of the tested lysine (Figure 2.2).  A threshold for prediction was also 
determined based on this plot. To test the significance of this score, I 
applied the above procedure to 1000 random permutations of the labels of 
the observed and not observed lysines.  The median AUC in these 
permutations was 0.64 and the maximum score was 0.79, and thus, my AUC 
was statistically significant (p<0.001).   
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Computational prediction of novel human histone acetylation marks 
and in vivo validation by mass spectrometry  
After hierarchical clustering of all the lysine-embedded histone 
sequences, I next sought to predict novel acetylation sites in the human core 
histones.  As the tree illustrates in Fig. 2.3, “not observed” lysines that 
clustered tightly with “validated” acetylated lysines (black arrows) were 
potential acetylation targets because of their similar sequence constitution. 
Based on the threshold, as determined by the ROC plot, I selected these as 
candidate sites. The method described above predicted seven novel 
acetylation sites in the human core histones; four in H2A (K9, K13, K125, 
K127), one in H2B (K116), one in H4 (K44), and one in H3 (K37) (Figure 
2.3; black arrows, for enlarged view of tree, please see Appendix). This 
large number of predictive sites was unexpected, since histones have been 
intensely investigated for PTMs in recent years.  I describe all details of my 
in vivo validation in Chapter 3.  In summary, I correctly predicted four of 
these seven acetyl-lysine sites suggesting that the algorithm is capable to 
identify acetylation sites in human histone proteins.  I also selected a small 
number of lysines that I predicted with high confidence as “not acetylated”.  
These lysines were H3K64 and H3K115, and preliminary results display that 
these lysines to my knowledge have not been observed as acetylated 















Figure 2.2:  Computational prediction of human histone acetylation sites 
ROC curve using LOV on the 56 human histone lysines for selected parameters. True 
positive rate (y axis) versus false positive rate (x axis). Win=(x,y) denotes the length of 
residues spanning the lysine; x represents the number of residues N-terminal to the lysine 
and y represents the number of residues C-terminal to the lysine. Win=4,3, AUC=0.74; 










Figure 2.3: Predictive hierarchical tree of all 56 lysines in human core histones  
Predictive tree of all 56 lysines from human core histone sequences using hierarchical 
clustering. Histone lysines (in red or green) are color coded according to published data on 
their modification state as described in Fig. 2.1E. For each pair of sequences under a single 
node, amino acids are colored in light purple (identical residues) or dark blue (in accordance 
with the BLOSUM matrix). Underlined red lysines represent the residue that was used for 
training the algorithm. Dashed red vertical line represents the selected threshold used to 
make predictions. Grey boxes represent lysines that cluster together. Black arrows 
represent those lysines predicted as acetylated. For an enlarged view of tree, please see 
Appendix. An “R” next to the lysine indicates that a C- to N-terminal arrangement was 
















Nonhistone sequence based dataset prediction and validation  
Since my computational analysis revealed a high level of sequence 
homogeneity among acetylated lysines within histone proteins, leading to 
the successful prediction of novel modified residues, I next wondered if my 
approach might also enable us to predict nonhistone acetylation sites as well  
(Figure 2.1F2).  In my first approach, I included a dataset that contained 
both nuclear and cytosolic proteins from HeLa cells, which were 
immunoprecipitated with a pan-acetyl antibody (Figure 2.4A) and identified 
by MS (Kim, Sprung et al. 2006) (see Appendix for full list).  The 
precipitate contained peptides with a total of 1413 lysines, and 51 previously 
validated acetylation sites. With PredMod, I was able to predict 34 (67%) of 
these sites correctly (Figure 2.4C) when they were surrounded by six 
residues to the left and right (AUC= 0.75, sensitivity (Sn)=0.60, specificity 
(Sp)=0.91) (Figure 2.4C; orange curve).  In total, 6% (85) of the total 
number of lysines were predicted that were not validated as acetylated (Fp 
< 6%).  Fp is a maximum false positive rate since a true negative count 
cannot be accurately determined because many of these lysines could 
potentially be acetylated, but not detected under the experimental 
procedures used.  
In my second dataset, I compiled a list of 32 proteins containing 1378 
lysines with 73 of these reported in literature to be acetylated in vivo and/or 
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in vitro (Figure 2.4B, see Appendix).  With PredMod, I predicted 39 out of 
73 (53%) lysine marks accurately with Fp < 6.5% (AUC= 0.74, Sn=0.58, 
Sp=0.91) when these were surrounded by six residues to the left and right 
(Figure 2.4D; orange).  
Both test datasets exhibited a decrease in performance when larger 
numbers of residues N- and C-terminal to the target lysine were used (blue 
line), suggesting that KATs may recognize a smaller and defined set of 
residues.  Overall, my results from both approaches revealed that my 
selected parameters for histones were also valid for the prediction of 


































Figure 2.4: Prediction performance on test set of human acetylated substrates.   
A. Pan-acetyl immunoprecipitated substrates. Black line represents the full-length protein. 
Red filled circles indicate lysines that are predicted and correctly validated in their positions 
relative to the full-length of the protein. Red empty circles indicate lysines predicted, but 
not validated under the experimental conditions tested in their positions relative to the full-
length of the protein.  
B. Literature validated human acetylated proteins. Symbols are the same as in A.  
C. ROC curve for human pan-acetyl IP substrate test set. Y axis represents the true positive 
rate and X axis the false positive rate. Win=(x,y) denotes the length of residues spanning 
the lysine; x: number of residues N-terminal to the lysine; y: number of residues C-terminal 
to the lysine. Diagonal line represents a random prediction.  


















Analysis of acetylation motifs 
I next sought to understand which amino acids play a critical role in 
acetylation site selection and asked whether there were preferences for 
certain amino acids near the target acetylated lysines in my datasets. 
Notably, when I examined the surrounding residues (six residues to the left 
and right) of a “validated” acetylated lysine versus a “not observed” one in 
human histone and nonhistone proteins I discovered an enrichment for small 
residues (G/A in pink), lysines (K in green), and phosphorylatable residues 
(S/T in blue) (Figure 2.5).  To test whether the observed enrichment of G, 
K, and S was statistically significant, I determined the frequency of these 
residues flanking a lysine in the entire human proteome.  I noticed that on 
average, these residues were of significantly higher frequency in my 
datasets than in the human proteome.  I employed the hypergeometric test 
to measure the statistical relevance of this observation. For a table with all 
the p-values of these statistical observations (see Appendix for full list of 
values).  
My results display that the most significant p-values were found in the 
category of small residues (p<0.01 in multiple flanking positions, Figure 
2.5, tick marks), suggesting that small amino acids, perhaps due to their 
sterically undemanding side chains, could accommodate the flexibility of the 
substrate thus allowing protein docking and catalysis.  This observation was 
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in agreement with a previous study (Schwartz, Chou et al. 2009), which 
revealed that glycine preceding lysine was common among acetylated 
lysines.  In conclusion, I was able to identify a significant enrichment of 
mainly small amino acids and lysines surrounding “validated” acetylated 
lysines in comparison to “not observed” ones, suggesting that KAT enzymes 
have a general need for specific residues for recognition and/or activity.  
These observations are in agreement with studies of several KATs with test 


































Figure 2.5: Frequency distribution of amino acids surrounding lysines in human 
histone and nonhistone proteins. 
A. Frequency of amino acids (Y-axis) spanning positions –6 to +6 (X-axis) in validated 
acetylated lysines in histone proteins (23 lysines). Residues in green: basic, red: 
hydrophobic, pink: small, blue: S/T, black: all other residues. Underlined red K: lysine that 
has been validated experimentally as acetylated, and an underlined green K: lysine that has 
not been experimentally observed as acetylated. “X” denotes that no amino was present in 
that position.  
B. Frequency of amino acids (Y-axis) spanning positions –6 to +6 (X-axis) in validated 
acetylated lysines within proteins in literature (73 lysines). Colors represented same as in A. 
C. Frequency of amino acids (Y-axis) spanning positions –6 to +6 (X-axis) in validated 
lysines in the pan-acetyl IP substrates (51 lysines). Colors represented same as in A.  
D. Frequency of amino acids (Y-axis) spanning positions –6 to +6 (X-axis) in “not observed 
as acetylated” lysines in histones (33 lysines). Colors represented same as in A.  
E. Frequency of amino acids (Y-axis) spanning positions –6 to +6 (X-axis)  not observed as 
acetylated lysines in proteins as reported in literature and not observed as acetylated 













S.cerevisiae proteome-wide prediction  
The previous predictions were performed with human proteins, and I 
therefore wondered whether my algorithm would also be able to predict 
acetylation sites in proteins from other organisms (Figure 2.1F3). Since 
histone acetylation has been studied extensively in budding yeast, I 
assessed the performance of my model on a proteome-wide dataset that 
included acetylated peptides in S. cerevisiae (Craig, Cortens et al. 2006) 
(see Appendix for details). In addition, I experimentally validated my 
predicted acetylation sites in candidate yeast nonhistone proteins in vivo.  
In my first approach, I examined an in vitro proteome-wide dataset of 
acetylated peptides of S. cerevisiae that contains 356 peptides including also 
acetylated histone peptides.  This dataset allowed me to approximate the 
number of yeast acetylation events on a global level (0.6%; 356 acetylated 
peptides out of approx. 50,000 total non-redundant peptides), and the 
substrates themselves allowed me to further validate my prediction 
algorithm.  I filtered these protein-derived peptides according to their 
cellular compartment (nuclear vs. cytoplasmic) (Huh, Falvo et al. 2003), and 
correctly predicted 48% of acetylation events on nuclear proteins (79 lysines 
total, AUC= 0.71, Sn=0.63, Sp=0.92, Fp < 4%), and 31% on the 
cytoplasmic proteins (248 lysines total, AUC= 0.70, Sn=0.61, Sp=0.90, Fp < 
5%) (Figure 2.6A, B).  I also noted that nuclear yeast proteins showed a 
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similar enrichment for small residues surrounding the target lysine, as found 
in the human substrates (Figure 2.7; tick marks).  Given the mass 
resolution of many of the spectra used to create the yeast library, it was not 
possible to distinguish a priori between acetyl-lysine and trimethyl-lysine on 
the basis of the tandem spectra alone.  Thus my yeast proteome-wide 
dataset could potentially contain tri-methylated peptides.  Since there are 
few reported trimethyl marks across the yeast proteome, and my dataset 
does not contain the previously validated yeast histone trimethylated sites 
H3K36, H3K79, and H3K4 (Garcia, Hake et al. 2007), I believe that the 
number of trimethyl sites in the dataset could be small. In accordance, my 
dataset contains the following peptides: H3K9 (Suka, Suka et al. 2001), 
H3K14 (Suka, Suka et al. 2001), H3K18 (Suka, Suka et al. 2001), H3K27 
(Suka, Suka et al. 2001), H3K56 (Xu, Zhang et al. 2005), H2BK11 (Suka, 
Suka et al. 2001), H2BK16 (Suka, Suka et al. 2001), H4K5 (Suka, Suka et 
al. 2001), H4K8 (Suka, Suka et al. 2001), H4K12 (Suka, Suka et al. 2001), 
and H4K16 (Suka, Suka et al. 2001); all yeast acetyl marks validated in 
literature. Of note, my current prediction accuracy could be limited by an 
underrepresentation of acetyl-lysines, and it would be interesting to see how 










Figure 2.6: Performance on Yeast Proteome-wide Dataset 
A. Pie chart reflecting correctly predicted lysines on nuclear versus cytosolic peptides in S. 
cerevisiae. Peptides were generated from Global Proteome Machine database. Nuclear 
peptides (108 peptides) and cytosolic peptides (248 peptides) shown.  
B. Performance accuracy (#correctly predicted as acetylated/total number of positives) and 
false positive rate on nuclear peptides versus cytosolic peptides. Individual training sets 
(histones, nuclear, and cytosolic proteins) used to perform accuracy. The first number in 
table cell reflects accuracy, and second number after the | reflects the percentage of lysines 
predicted as acetylated in the test dataset (Fp).  
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Figure 2.7: Frequency distribution of amino acids surrounding yeast lysines 
A. Frequency of amino acids (Y-axis) spanning positions –6 to +6 (X-axis) in validated 
acetylated lysines in yeast nuclear histone and nonhistone proteins (108 lysines). Residues 
in green: basic, red: hydrophobic, pink: small, blue: S/T, black: all other residues. 
Underlined red K: lysine that has been validated experimentally as acetylated, and an 
underlined green K: lysine that has not been experimentally observed as acetylated. Tick 
marks represent residues described in text.   
B. Frequency of amino acids in validated acetylated lysines in yeast nuclear proteins 
excluding histones (79 lysines). Colors are as in A.  
C. Frequency of amino acids in validated acetylated lysines in yeast cytosolic proteins (248 
lysines). Colors are as in A.  
D.  Frequency of amino acids in not observed as acetylated lysines in yeast nuclear and 
cytosolic nonhistones (13814 lysines). Colors are as in A. 
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In my second approach, I validated my predictions on three yeast 
candidate proteins that had previously not been published to contain 
acetylated sites (Spt6 (Clark-Adams and Winston 1987), Sir3 (Gasser and 
Cockell 2001), and Eaf7 (Krogan, Baetz et al. 2004).  With PredMod, I 
predicted 15 sites to be acetylated out of 416 total lysines in my three 
candidate proteins combined.  Four of these, within my top six ranked 
predicted sites were validated as acetylated by MS and therefore predicted 
correctly (more detail in Chapter 3).  Since the total number of acetylated 
lysines in the yeast proteome is approximately 0.6% my in vivo hit rate of 
approximately 25% is of reasonable accuracy.  
Finally, in order to allow users to view predictions of their favorite 
protein, I developed a software tool, PredMod, which allows a user to enter a 
protein of choice and view all lysines, with their respective confidence scores 
with which they are predicted (Figure 2.8)(described further in Appendix). 
Users can also view lysine predictions of substrates that were contained in 
both independent validation sets as well as histone proteins including 
variants in multiple organisms.  In the future, PredMod will potentially be 
powerful for identifying bonafide acetylation sites in nonhistone proteins, and 
further display the strength of using histone sequences as a useful guide for 








Figure 2.8: PredMod, an acetylation prediction tool 
PredMod, an acetylation prediction tool was developed for a user to enter a protein of choice 











Chapter 2 Discussion 
My results suggest that the “sequence environment” in both histone and 
nonhistone proteins contributes to the likelihood of acetylation.  Consistent 
across both human and yeast acetyl datasets, I noticed an enrichment of 
small residues, particularly glycine, and charged amino acids flanking 
validated acetylated lysines (Figure 2.5, Figure 2.7; tick marks).  It is 
possible that I am perhaps achieving a higher accuracy for nuclear proteins, 
since the KAT substrates (histones) I used for training PredMod, mostly 
reside in the nucleus.  My results also suggest that nuclear versus 
cytoplasmic KATs in yeast could possess unique substrate recognition 
profiles as illustrated by the differences in preferred flanking residues C-
terminal to the lysine (Figure 2.7).  In order to address whether histones 
were the best training set for nonhistone prediction, I retrained my 
algorithm with nonhistone lysines exclusively.  I compiled lysines in both the 
literature scanned and pan-acetyl datasets together, and observed whether I 
would perform better using the nonhistone set for training purposes.  I used 
five-fold cross validation on the datasets, thereby training on 4/5 of the 
dataset, and retesting on 1/5 of the dataset.  I obtained an accuracy of 65% 
when training on histones, and 60% when training on nonhistones.  When I 
trained on nonhistones to predict histones sites also using cross validation, I 
obtained 54%. Interestingly, I achieved a higher accuracy when training on 
histone versus nonhistone proteins. This could be due to the fact that in my 
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nonhistone dataset, I have a heterogeneous distribution of enzymes, due to 
the fact that this set contains both nuclear and cytosolic proteins. A 
compartmentalization between nuclear and cytoplasmic proteins could help 
achieve better results.  
In my computational analysis, as shown in Figure 2.5, I observed that 
15 out of the 51 pan-acetyl lysine substrates contained a histidine adjacent 
to the lysine (C-terminal) (Figure 2.5C).  It is possible that this pan-acetyl 
antibody has a specific preference for histidine immediately adjacent to the 
acetylated lysine (Figure 2.5C).  Whether the observed enrichment of 
histidines is due to a bias of the antibody or whether it could be part of a 
KAT recognition motif needs to be further explored.  In contrast to the 
enrichment of small residues flanking validated acetylated lysines, I did not 
observe an enrichment of small amino acids surrounding “not observed” 
lysines in human histones and nonhistones therefore strengthen my 
confidence in the pronounced signal among acetylated lysines (Figure 
2.5D,E). 
An area that was unexplored  that would be interesting to delve into is 
whether structural information could add to the predictive power of the 
algorithm.  Thus, if a given lysine is located within a loop, beta-strand or 
alpha-helix, I can add this information onto the algorithm, where a lysine 
within the loop region would be more exposed than a lysine within a beta-
strand.  Current structural prediction programs such as Psi-Pred and other 
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prediction programs can aid in predicting these regions, and as a result the 
misclassified data may become true positives.  
The prediction program, PredMod that I developed is a promising step 
in detecting additional novel acetylation sites.  A study that has been 
recently published involves a quantitative proteomics approach to detect 
acetylation substrates (Choudhary, Kumar et al. 2009). One of the major 
findings of the study is that lysine characteristics of sequences in 
mitochondria, nuclear, and the cytoplasm are divergent from each other 
(Choudhary, Kumar et al. 2009). They observed the following results: all 
acetylated substrates have high frequency of tyrosines in the +1 position.  I 
suspect that this could be due to the bias of pan-acetyl antibody that was 
used in their study, which resembles the high frequency of histidine in the 
+1 position on my pan-acetyl antibody dataset.  In agreement with my 
analysis, they find an enrichment for glycine in the -1 position within their 
nuclear acetyl sites, unlike the cytosolic sites that do not show this type of 
preference.  They also discover a high frequency of lysines surrounding 
acetylated lysines, which is also in agreement with my studies.  Conclusions 
such as this from these types of large scale studies makes me curious as to 
whether incorporating other modifications that are potentially on the same 
peptide could be included into the algorithm.  Since it is known that there is 
cross-regulation occurring between modifications on histone tails, and even 
nonhistones, a parameter that I could add to the algorithm would be to 
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include other modifications that are present within the flanking residues of a 
target lysine. Information on additional peptide modifications from the 
Global Proteome Machine Database (GPMDB) would be useful to incorporate 
on a proteome-wide scale.  In the early stages when I was developing the 
algorithm, I utilized this same approach on histone modifications in order to 
derive whether multiple modifications within the same region of the histone 
would influence my histone predictions overall.  For example, if the target 
lysine was H3K9ac, instead of representing the +1 residue relative to H3K9 
as H3S10, this residue was represented as phosphorylated H3S10. Using this 
method, I achieved an accuracy of 70%, which is lower than my current 
prediction accuracy.  One possibility of why I may have been achieving a 
lower prediction accuracy could be that I was overspecifying the training set, 
resulting in some of the true positives being missed.  More complete 
quantitative data such as the abundance levels of additional PTMs, could be 
crucial for my algorithm performance.   
Overall, my results suggest that KATs target specific sequence 
patterns, and that the predictive knowledge about histone acetylation 
provides a platform for studying both histone and nonhistone lysine 
acetylation.  My model and results represent a step towards gaining a 
framework for predicting lysine acetylation sites in both human and yeast 
proteomes.  It will be of interest in future studies to see whether my 
algorithm is capable of predicting lysine acetylation sites in many other 
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organisms.  As more substrates in the acetyl-proteome are discovered (Yang 
and Seto 2008), it is likely that the predictive power of my approach will be 
strengthened, leading to more accurate confidence in the predicted site. 
Though my training dataset is 10-100 times in magnitude lower than other 
PTM datasets including acetylation (9, 21, 22), my approximate sensitivity 
measure of 60% is comparable and often higher than other prediction 
algorithms that achieve as low as 16-18% sensitivity (Blom, Sicheritz-
Ponten et al. 2004; Saunders, Brinkworth et al. 2008; Schwartz, Chou et al. 
2009). It would be interesting to see whether similar approaches could be 
applied to the prediction of other widespread histone modifications such as 















Chapter 3: Experimental validation of predicted acetylation targets  
Summary 
In this chapter, I describe the validation of my computationally predicted 
targets through wet-bench experiments that I performed in the Allis 
laboratory.  In collaboration with the Don Hunt laboratory at the University 
of Virginia (Charlottesville, VA), and the Yingming Zhao laboratory at the 
University of Texas Southwestern Medical Center (Dallas, TX), I describe 
several novel acetylation marks in human histones and yeast nonhistone 
proteins that were correctly validated through my computationally oriented 
algorithm (as described in Chapter 2) via mass spectrometry.  These marks 
further validate my computational algorithm and illustrate that primary 
sequence context of histone and nonhistone lysines are a driving factor in 
acetylation target and recognition.  In addition, in order to determine 
acetyltransferase rules and pinpoint residues that could be critical for 
enzymatic recognition, I present data on yeast mutagenesis experiments 
that I performed in histone H3 in collaboration with the Ben Garcia 
laboratory at Princeton University (Princeton, NJ).  These results have led to 







In vivo validation by mass spectrometry  
In Chapter 2, I described the computational method that I used in 
order to predict acetylation marks in histone and nonhistone proteins. As 
described in Chapter 2, I predicted seven novel acetylation sites in the 
human core histones; four in H2A (K9, K13, K125, K127), one in H2B 
(K116), one in H4 (K44), and one in H3 (K37) (Figure 2.3).  This large 
number of predicted sites was unexpected, since histones have been 
intensely investigated for PTMs in recent years.  To test whether these 
predicted lysines are acetylated in vivo, the Don Hunt lab employed an MS-
based approach to examine histone peptides from human cell lines (Hela and 
HL60) that were asynchronously growing and treated without any HDAC 
inhibitors.  HDAC inhibitors were excluded so that I could capture the non-
hyper levels of acetylation in the asynchronously growing cells.   All peptides 
containing the predicted lysines were identified, and importantly four of the 
seven predicted acetyl-lysines were experimentally validated: H2AK9, 
H2AK13, H2AK125, H2AK127 (Figure 3.1). In collaboration with the Ben 
Garcia lab, I also looked at histone acetylation marks under sodium butyrate 
treatment (an HDAC inhibitor), to assess whether this condition would result 
in an altogether different set of acetylation marks which could potentially 
alter my training set composition or prediction accuracy on the algorithm.  
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Under sodium-butyrate treatment, Hela cells displayed H3K37 and H2BK116 
acetylation, two of my predicted acetylation sites, (personal communication, 
Ben Garcia), however since these marks were only observed under these 
special conditions, I did not count them as bonafide “validated” sites. 
Additional acetyl marks observed under sodium butyrate treatment were: 
K95, K119 in H2A; K34, K46, K108, K116 in H2B; K77, K79, K91 in H4, and 
K37 in H3.  Incorporating these sites into my training set of “validated” 
lysines did not alter the prediction performance of my algorithm significantly.  
In summary, I correctly predicted four of these seven acetyl-lysine 
sites suggesting that the algorithm is capable to identify acetylation sites in 

























Figure 3.1: Validation on histone predicted lysines  
Human H2A and H2B, H3, and H4 sequences are shown. Literature-validated acetylated 
lysines are red, and lysines which have not been observed as acetylated are green. Lysines 
in blue under filled green circle were not predicted as acetylated, but validated under 
experimental conditions tested using LC/MS/MS. Lysines in blue under filled red circle were 
predicted as acetylated, and validated under experimental conditions tested using 
LC/MS/MS. Lysines in green under open red circle were predicted as acetylated, but have 




Yeast in vivo validation  
The previous predictions were made on human histone and nonhistone 
datasets, and I therefore wondered whether my algorithm would also be 
able to predict acetylation sites in proteins from other organisms. Since 
histone acetylation has been studied extensively in budding yeast, I 
assessed the performance of my model on a proteome-wide dataset that 
included acetylated peptides in S. cerevisiae (Craig, Cortens et al. 2006) 
(Chapter 2). In addition, I experimentally validated predicted acetylation 
sites in candidate yeast nonhistone proteins in vivo. 
An outline of my overall approach and method is as follows: I) I  ran 
the algorithm against the 30 chromatin-associated proteins (of interest to 
the Allis Lab) in the S. cerevisiae proteome by taking a sequence stretch of 
six residues N- and C-terminal to the target lysine because of the promising 
human ROC results. I used the nonhistone lysine traversal method described 
in Chapter 2 and applied to the human histone-trained tree to find which 
subgroup of sequences the nonhistone yeast sequence formed the tightest 
cluster with. Based on the threshold score that was determined by the 
human ROC analysis, I then selected candidate proteins that had the highest 
scoring alignments with acetylated histone sequences.  The highest ranked 
predicted lysine acetylation sites were in the proteins Cac2 (component of 
the chromatin assembly complex) (Enomoto and Berman 1998), Spt6 (a 
transcriptional elongation factor and nucleosome disassembly factor) (Clark-
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Adams and Winston 1987), Sir3 (a silencing factor that establishes a 
transcriptionally silent chromatin state) (Gasser and Cockell 2001), and Eaf7 
(an Esa1 associated factor) (Krogan, Baetz et al. 2004).  Additionally, for 
each of these proteins, I ranked in order of confidence lysines that would be 
predicted as likely KAT targets. III) I then purified my candidate proteins by 
performing a TAP purification (Figure 3.2A) and subsequently analyzed 
these via mass spectrometry according to previously published rules (Chen, 
Kwon et al. 2005). 
In conclusion, I validated my predictions on three yeast candidate 
proteins that had previously not been published to contain acetylated sites 
(Spt6 (Clark-Adams and Winston 1987), Sir3 (Gasser and Cockell 2001), 
and Eaf7 (Krogan, Baetz et al. 2004).  I expressed and purified the TAP-
tagged candidate proteins in S. cerevisiae (Figure 3.2A) and subsequently 
subjected them to LC/MS/MS.  With PredMod, I predicted 15 sites to be 
acetylated out of 416 total lysines in three candidate proteins combined. 
Four of these, within the top six ranked predicted sites (Figure 3.2B,C,D), 
were validated as acetylated by MS and therefore predicted correctly 
(Figure 3.2B,C,D). Since the total number of acetylated lysines in the yeast 
proteome is approximately 0.6% (discussed in Chapter 2), my in vivo hit 
rate of approximately 25% is of reasonable accuracy.  
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These results demonstrate the power of PredMod for identifying bona 
fide acetylation sites in nonhistone proteins, and further display the strength 









































Figure 3.2: Novel predictions and in-vivo validations in S. cerevisiae 
A.  Coomassie-stained gel of TAP pulldown purification of yeast proteins Eaf7, Sir3, and 
Spt6. Asterisks denote bands that were isolated and inspected for acetylation by MS.  
B-D. Shown are regions of the sequence alignment where there is sequence identity or 
similarity.  A purple pair of amino acids represents identical residues and a blue pair of 
amino acids represents residues that can be evolutionarily substitutable in accordance with 
the BLOSUM matrix. A black bar below the alignment represents the length of nonhistone 
protein. The numbers to the right represent the total number of amino acids (aa) and the 
number of lysines (K) in the protein. Red filled circles depict lysines that were predicted 
correctly on the yeast nonhistone substrate at the specific location relative to the full length 
of the protein. Red empty circles represent lysines that were predicted, but not confirmed 
by mass spectrometry under the conditions tested. Green filled circles represent lysines that 
were not predicted, but validated experimentally by MS.  A blue lysine with a red filled circle 
on top represents those lysines that were correctly predicted. Boxed R represents the rank 
of prediction among all predicted acetylated sites on the protein. B. Eaf7K343 (R=2) 
sequence alignment with H4K5. C. Sir3K3 (R=4) sequence alignment with H3K56. Symbols 
denoted as in B. D. Spt6K958 (R=1) and Spt6K319 (R=6) sequence alignments with H4K5 














In vivo mutagenesis in budding yeast 
My computational analysis in Chapter 2 led me to conduct experiments that 
could help identify rules, or specific patterns that could potentially be 
important for acetyltransferase recognition in order to address the question: 
is immediate sequence context of lysine important in HAT recognition? From 
my statistical and quantitative analysis methods, I came to the conclusion 
that sequence context surrounding a target acetylated lysine can dictate KAT 
substrate preferences.  However, to fully test the effectiveness of my 
approach, I wanted to perform specific wet-bench experiments to formalize 
the rules necessary for enzyme recognition.  Since my computational 
analysis led to a frequency enrichment analysis of flanking residues 
surrounding an acetylated lysine, I wanted to mutate these residues in vivo 
to determine what effects these mutations might have on known PTMs.  I 
chose S. cerevisiae as the organism to perform site-directed mutagenesis in 
because of its robust genetic manipulation techniques and easily available 
reagents.  Additionally, yeast H3 and H4 are highly conserved with human 
H3 and H4 which were a part of the training set the algorithm was based on.  
My first step was to examine the hierarchical tree in Chapter 2 (Figure 2.3), 
in order to determine whether there were lysine embedded sequences under 
the same cluster with similar flanking sequence profiles.  
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Via the clustering analysis, I singled out a cluster containing two 
sequences that were tightly paired (ranked as the tightest pair of sequences 
in the tree).  As shown in Fig 3.3A, these sequences were H3K14 and 
H3K36. Close examination of the sequence alignment of these two 
sequences reveals phosphorylatable residues in the -4 position, glycine in 
the –1 position (small), a proline in the +2 position, and a basic residue in 
the +3 position (Figure 3.3A).  Also, H3K14 and H3K36 are both Gcn5-
mediated acetyl sites (Howe, Auston et al. 2001; Morris, Rao et al. 2007).  
Furthermore, H3K36 is a bonafide trimethyl site, where the methylation of 
this site occurs via the methyltransferase, Set2 (Strahl, Grant et al. 2002).  
Additionally, both of these acetyl sites are associated with transcriptional 
activation (Pokholok, Harbison et al. 2005), and H3K36me2 and H3K36me3 
are associated with transcriptional elongation, and are needed to prevent 
cryptic initiation (Kizer, Phatnani et al. 2005; Morris, Shibata et al. 2005).  
The distinct functional roles of H3K36 acetylation and methylation made me 
curious as to whether H3K14, a bonafide acetyl site, could also be 
methylated if its sequence was mutated to resemble H3K36’s.  I next 
checked whether there was an existing literature of H3K14 methylation in 
yeast.  To my knowledge, there is no published literature of H3K14 
methylation in organisms ranging from mammals to yeast to date (Garcia, 
Hake et al. 2007).  
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In order to address the question of whether H3K14 is methylated after 
mutagenesis within the flanking residues, I mutagenized the flanking 
residues of H3K14 to resemble H3K36.  A key question that I could also 
attempt to answer in parallel through these experiments was: how do H3K14 
acetylation levels fluctuate as a result of specific mutations?  The table below 
(Table 3.1) displays the mutations that I chose to make, the rationale 
behind why selecting these mutations would enable me to learn something 
about acetylation based on my computationally derived frequency analysis 
(Figures 2.5, 2.7), and a prediction of how acetylation levels would 
increase or decrease upon making the selected mutations, which were 
designed to resemble the flanking H3K36 sequence profile (Figure 3.3B):       
Table 3.1: Mutations, Rationale, and Acetylation Prediction           
Mutation Rationale  Acetylation Prediction  
G13->V       Valine is beta branched and more 
conformationally rigid as opposed to 
glycine with a flexible side chain. 
Acetylation will be decreased, as 
glycines are enriched on the N-terminal 
side of an acetylated lysine. 
A15->V Control. Since I mutated G13 to V 
on the left, a parallel mutation on 
the right is a good control.  
No change. Valines are present in the 
+1 position of acetylated substrates 
A15->K Lysine is a charged amino acid. Do 
two adjacent charged residues have 
an effect on lysine acetylation or 
methylation?  
Acetylation could increase or decrease. 
There are lysines in the +1 positions of  
acetylated substrates, and in the “not 
observed as acetylated” substrates.  
G13->V, 
A15->K 
Double mutation, identical  residues 
surrounding H3K36 
Decrease in acetylation mainly caused 
by the G13V mutation. 
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Figure 3.3: Mutagenized yeast histones  
 A. Blast sequence alignment between H3K14 and H3K36. Both sites are acetylated by Gcn5 
and H3K36me can be mono, di, or tri-methylated. Colored residues either identical or 
similar according to BLOSUM matrix(Eddy 2004).  
B. Mutations that were made in H3 of budding yeast in vivo. Effect of methylation and 
acetylation levels as a result of mutagenesis was the question I tried to answer in study. 
C. Acid extracted histones (1 microgram) were electrophoresed in a 15% SDS-PAGE and 
analyzed by Western blot. Shown is the marker (left) and the three strains that histones 
were extracted from (right 3 lanes). These strains are WT, H3G13V, H3A15K, and H3A15V. 
Untagged H3 (shown in second lane), and Myc-tagged H3 is shown with arrow (all other 
lanes).  
D. Western Blot using a general H3 antibody (Abcam) with same fractions as in C, 
electrophoresed in a 15% SDS-PAGE gel.    
E. Western Blot using H3K9ac (Abcam) and H3K23ac antibodies (Abcam) to display that 
Myc-tag on the mutant strains did not affect acetylation levels of H3. Strains are H3A15K 





















I used a budding yeast plasmid shuffle strain (detail described in 
Methods) to perform yeast mutagenesis by making the following H3 shuffle 
plasmid mutations: H3A15K, H3G13V, and H3A15V.  In the strain that I 
wanted to make these mutations in, I shuffled out the WT plasmid and 
inserted my mutant plasmid containing my desired mutation.  To check 
whether my strains had the correct mutations, I performed a plasmid 
recovery followed by DNA sequencing.  Once I confirmed that I had the 
correct mutations in my yeast strains, I extracted yeast nuclei through 
douncing and spheroplasting, and used an acid extraction procedure of 
histone proteins (Figure 3.3C, D).  Since the mutant strains were tagged 
with a N-terminal Myc tag, I was concerned that the Myc-tagging could alter 
the acetylation status of histone H3.  Thus, I checked acetylation levels of 
my WT versus mutant strains against the general H3, H3K9ac, and H3K23ac 
antibodies (Figure 3.3D, E).  In the mutants, acetylation was at a 
comparable level to WT acetylation levels, suggesting that the Myc tag did 
not grossly affect levels of acetylation.  In collaboration with the Ben Garcia 
laboratory at Princeton University, mass spectrometry analysis of WT and 
mutant H3 was performed using LC/MS/MS, and the following results were 
revealed:  there was no methylation visible on H3K14 in either the WT or 
any of the mutant strains.  The double mutant strain (G13V, A15K) 
displayed a lethality phenotype.  While this could be interesting and worth 
investigating, I chose not to follow up on it further at the moment.  In all my 
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mutant strains excluding my designated control (A15V), H3K14 acetylation 
was decreased (Figure 3.4A); the most significant decrease was under the 
alanine to lysine mutation in the +1 position as H3K14 decreased by four- 
fold (Figure 3.4A).  Under this same mutation, H3K9ac increased by 
approximately two fold.  To my surprise, methylation levels of H3K36 were 
also affected under the A15K mutation.  I did not expect that distorting the 
sequence immediately surrounding H3K14 would have such a pronounced 
effect on H3K36 methylation levels, such that the unmodified form of H3K36 
increased twenty fold, H3K36 monomethyl increased ten-fold (H3K36me1), 
while H3K36 dimethyl (H3K36me2) and trimethyl (H3K36me3) levels 
decreased by 1.5 fold (Figure 3.4 illustrates the exact values). Errors not 
shown in figures as the experiments were performed only once. All mass 





















Figure 3.4: PTMs as result of flanking residue mutations surrounding H3K14  
A. Table displaying H3K9ac, H3K14ac,H3K36ac, H3K36me0, H3K36me1, H3K36me2, and 
H3K36me3 levels as a result of making mutations H3A15K, H3G13V, and H3A15V. Numbers 
represent percentage of the total that is modified. Yellow highlighted numbers represent 
mutations where there were dramatic increases or decreases.  
B. Bar graphs displaying values as denoted in (A) for both H3K14 and H3K36 peptides. Note 






















Chapter 3 Discussion 
Here I show that I can predict novel acetylation sites in proteins of interest 
in both human and yeast cells.  Furthermore, I have shown that there are 
residues that may be critical for lysine acetyltransferase recognition and 
demonstrated that there could be a “crosstalk” occurring between three 
marks on the histone H3 tail H3K9, H3K14, and H3K36.  Together my data 
can lead to a predictive understanding of acetylation by examining the 
sequence of the targets themselves.  
Using a combined experimental/computational approach, I identified 
several sites in human histone and nonhistone proteins that were correctly 
predicted.  There were, however, a class of lysines that were predicted by 
my algorithm, yet have not yet been detected experimentally.  Several 
possibilities can be envisioned for this case: first, the MS approach has 
limited detection and sensitivity capabilities and cannot recover peptides that 
are acetylated at only low levels.  Second, lysines could be modified only in 
distinct environmental conditions, cell cycle stages, cell types, and are 
therefore undetectable in the cell extracts I used.  Here it should be noted 
that additional novel histones acetylation sites were detected by MS/MS 
when Hela cells were pretreated with HDAC inhibitors (personal 
communication, B. Garcia), and I retrained the algorithm with this data. 
Preliminary results from this analysis display that the predictive power of my 
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overall approach is not altered significantly, thereby increasing further 
confidence in the power of my approach.  Third, acetylation might be 
inhibited by adjacent PTMs (negative crosstalk), and therefore the 
responsible KAT might be prevented from binding to or accessing its target 
site.  Finally, acetylation is a dynamic, transient modification, and thus MS 
results may depend on a time-specific acetylation state whose kinetic 
properties have not been adequately captured by the experimental 
parameters.  Of interest is the class of lysines in histones that were not 
predicted by the algorithm, yet were detected by MS, and which might 
indicate a different class of KATs that need special sequence surroundings.  I 
observed that one of these lysines, H2AK129, did not contain a full set of 
flanking residues C-terminal to the lysine, which put this lysine at a 
“disadvantage” compared to other lysines with a full set of flanking residues. 
H2AK15 failed to overall strongly resemble the other acetylated histone 
lysines in my training set by sequence, and therefore was not predicted. This 
could be due to the training set containing an underrepresented number of 
HATs, assuming that clusters of sequences under a single node represent 
similar enzyme recognition.  
In this chapter, I also addressed whether sequence surrounding an 
acetylated lysine can drives HAT recognition by performing site directed 
mutagenesis in vivo.  My results display that in the H3A15K background, 
H3K14ac decreases 3.5 fold, while H3K9ac increases almost two fold.  
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H3K36me levels are dramatically affected with a twenty fold increase of the 
unmodified form of H3K36.  Thus, H3K14 disruption could be promoting 
H3K9ac due to the steric binding of the H3K14 acetylation effector, Rsc4 
(VanDemark, Kasten et al. 2007) (Figure 3.5).  Similarly, H3K14 disruption 
could be acting in an inhibitory manner to H3K36 di and tri methylation, 
suggesting that H3K14ac is required for normal levels H3K36 methylation 
(Figure 3.5).  To my knowledge so far, acetylation of H3K14 by the NuA3 
KAT requires prior methylation of H3K36, although the mechanism remains 
to be determined (Latham and Dent 2007).  My model suggests that perhaps 
H3K14ac promotes H3K36 methylation by inhibition of demethylase activity, 
or by post-translational modifications in the vicinity of these two marks that 
are also involved in crosstalk (Figure 3.5).  Further mutagenesis 
experiments would have to be performed in order to fully explore this 
hypothesis.  Some preliminary experiments that I suggest are: (1) In 
budding yeast, design a strain with the H3K14R mutation, and observe 
whether H3K9ac levels decrease, and H3K36me0 and H3K36me1 levels 
increase using H3K9ac and H3K36me1 antibodies via western blotting. The 
result would reveal the distinct nature of the H3A15K mutation against the 
H3K14R effects. (2) Make Rsc4 bromodomain mutations in WT cells, so that 
H3K14 binding to Rsc4 is abolished.  Observe H3K9ac and H3K36me levels 
as a result; my above stated hypothesis suggests that H3K9ac would 
increase as a result.  These preliminary experiments could help us learn 
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more about the crosstalk biology and can guide us to better understand the 
orchestration of specific H3 acetylation, deacetylation, methylation, and 
demethylation events.  
 
Figure 3.5: Crosstalk Model  
A. In the wildtype background, Gcn5 acetylates H3K9ac. The Rsc4 ( bromodomain ) binds 
H3K14ac causing a steric occlusion of Gcn5 to acetylate H3K9.  
B. In the mutant background, Gcn5 does not recognize its preferred site, and acetylates 
H3K9. An inhibitory mechanism causes disruption of H3K36 di and trimethyl. Dashed lines 




One outstanding question that remains is what the algorithm presents 
regarding enzyme specificity within the hierarchical tree.  Does the 
alignment of acetyl sites actually predict the HAT for those sites, and do 
KATs have characteristic lysine containing motifs that they will target?  
Through my method, I suggest that there may be an intrinsic substrate 
specificity for acetyltransferases in general.  Whether computational rules 
can then be subgrouped into rules specific for each enzyme is a question 
that I would like to address.  In order to achieve this, I revisited my tight 
cluster (H3K14 and H3K36), both Gcn5 dependent marks.  I then ran my 
algorithm against validated nonhistone acetylated proteins and traversed 
these lysines through the histone-trained tree.  I observed that there were 
nonhistone proteins, particularly those that were Gcn5-mediated, that 
clustered very tightly within a specific region of the histone trained tree 
(Figure 3.6).  Recently, an essential chromatin remodeling factor Rsc4 was 
uncovered as acetylated at K25 in S. cerevisiae (VanDemark, Kasten et al. 
2007).  When I ran the Rsc4 protein against my algorithm, I noticed that 
K25 clustered tightly with cluster, and thus were able to predict this 
correctly (Figure 3.6) ((Howe, Auston et al. 2001), (Morris, Rao et al. 2007; 
VanDemark, Kasten et al. 2007)).  Interestingly, a recent study of the ISWI 
protein in Drosophila reveals that it’s acetylated at K753, dependent on 
Gcn5, and also has a G and P in its sequence (Ferreira, Eberharter et al. 
2007)(Figure 3.6).  Close analysis of the sequences under this cluster 
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revealed that there was sequence identity and similarity in the flanking 
residues of the lysine, and thus I was interested in whether acetylation of a 
lysine is programmed by its surrounding residues and whether there were 




Figure 3.6: Sequence alignment of Gcn5 mediated substrates 
Sequence alignment displaying H3K14, H3K36, ISWIK753, Cpr1K25, and Rsc4K25.  I 
predict that Cpr1K25 is acetylated by Gcn5, the primary enzyme for all the other substrates 




Alignment of the flanking residues of the surrounding lysines within 
the cluster (Figure 3.6; grey box) revealed that all four substrates have 
either a S/T/Y residue and a glycine flanking the left side of the lysine nearly 
at the same position.  I also noticed that all four substrates have a proline in 
the +2 position and a basic residue H/R/K in the +3 position (Figure 3.6). 
Next, I ran all yeast proteins through my algorithm, and detected proteins 
that contained a G-K-X-P sequence. One such protein was Cpr1, a peptidyl 
prolyl isomerase (Arevalo-Rodriguez, Wu et al. 2004) that clustered with this 
particular group of G-K-X-P sequences.  Whether or not this substrate is 
Gcn5 mediated will be an interesting question to answer and is something I 















Chapter 4: Domain prediction of chromatin-associated proteins 
Summary   
Protein domain prediction is important for protein structure determination, 
functional annotation, and mutagenesis among other things.  Most 
eukaryotic proteins receive and process signals which are constructed in a 
modular fashion from a combination of interaction and catalytic domains 
(Zarrinpar, Bhattacharyya et al. 2003).  These interaction domains mediate 
the formation of multiprotein complexes that restrict signaling proteins to 
appropriate subcellular locations and help determine the specificity of 
enzyme-substrate interactions.  Thus, being able to identify these domains 
using computational and structure based approaches is an important 
precursor for a range of methods.  While Chapters 2 and 3 were focused on 
“writer” recognition, in this chapter I discuss “readers” or effector domains 
that specifically bind PTMs, and describe computational approaches used to 
predict additional unannotated or cryptic domains.  I focus on the chromatin-
associated Polycomb Group (PcG) proteins, since these proteins contain 
highly conserved key domains throughout evolution, yet their substrate 
specificities are highly dissimilar contributing in part to their protein 
complexity.  Being able to predict additional domains and motifs outside of 
the key domains could help gain insight into their functional versatility.  
Since PcG proteins have diverged significantly from their Drosophila 
101 
 
counterparts and from their paralogs, I use my domain detection approach 
to infer co-evolution and expansion of these proteins in closely related and 
distant organisms.  In the first part of the chapter, I present the 
diversification of PcG homolog genes in the context of development and 
cellular differentiation in species ranging from plant to human, as part of a 
collaboration with two of my Allis lab colleagues, Sarah Whitcomb and Emily 
Bernstein (former member of Allis Lab).  In the second part of this chapter, I 
use existing bioinformatic methods to discover additional chromatin-
associated effector proteins that bind PTMs.  These effectors can potentially 
be important for downstream signaling and recruitment events.  
Results 
Conservation and diversification of PcG homologs  
I developed a bioinformatics method to discover key domains of PcG 
homologs.  Key domains of PcG homologs are highly conserved between 
evolutionarily distant organisms (orthologs) and among paralogs in a given 
organism (typically >75% amino acid similarity).  However, outside of key 
domains, PcG proteins have diverged significantly from their Drosophila 
counterparts and from their paralogs.  An important challenge is to 
understand the functional significance of developmentally regulated 
expression of orthologs and how this impacts PRC composition, genomic 
targeting and/or mechanism of transcriptional repression. To illustrate the 
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functional diversification of PcG paralogs, I focused on homologs of 
Drosophila Pc, Psc, dRing and E(z). 
The  bioinformatics algorithm that I developed consisted of the 
following steps:  (1) Selection of E(z), Pc, dRing and Psc as the PcG 
reference set: the “writer” (E(z)) and the “reader” (Pc) of the H3K27me 
mark, the only other known catalytic member of the PcG (dRing), and 
dRing’s associated factor (Psc).  Sequence and domain information was 
retrieved for Drosophila, mouse, and human PcG proteins from the 
Swissprot, Uniprot, Ensembl, and SMART (Ponting, Schultz et al. 1999)  
databases. (2) In order to identify putative homologs of these proteins in 
other organisms, I performed BLAST searches using the Drosophila, mouse 
and human proteins as queries (Altschul, Gish et al. 1990; Altschul, Madden 
et al. 1997).  The Blastp searches, using the NCBI web server 
(http://www.ncbi.nlm.nih.gov/BLAST) were performed at low, medium, and 
high stringencies to obtain all possible proteins in the following organisms: 
Arabidopsis thaliana, Caenorhabditis elegans (worm),Strongylocentrotus 
purpuratus (sea urchin), Danio rerio (zebrafish), Xenopus laevis (frog), 
Gallus Gallus (chicken), Canis familiaris (dog), Mus musculus (mouse), and 
Homo sapiens (human).  Since homologous domains between species were 
very well conserved, variation of BLAST parameters such as gap costs and 
substitution matrices did not significantly alter my results. (3) I developed a 
custom made algorithm to query motifs less than 15 amino acids in length 
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such as the Pc box.  Sequence similarity between homologous domains and 
full-length sequences was used to compute a weighted score by multiplying 
a fixed weight to the BLAST score and computing an overall weighted sum.  
Key domains for PcG proteins were identified including: the chromodomain 
and Pc-box for Pc homologs, the RING domain for Psc and dRing homologs, 
and the SET and SANT domains for E(z) homologs (Figure 4.1).  A list of 
putative homologs containing the highest scores was compiled for each class 
of PcG proteins, and homologs in different species were selected by manual 
inspection. (4) Finally, the ClustalW (Thompson, Higgins et al. 1994)  
program was used to cluster putative homologs to ensure that proteins with 
similar key domains with minor amino acid differences such as Ring1A and 
Ring1B were categorized correctly.  In addition, a reverse BLAST of all the 
putative homologs was also performed against the Drosophila genome to 
ensure that the forward BLAST hit was accurate. Many databases of 
translated cDNA libraries are inherently incomplete, and so gene sequences 
of those PcG homologs that were found to be absent in a given organism 
were also queried against the predicted ORFs from that organism’s genome.  
Finally, putative PcG homologs were mapped onto a phylogenetic tree of 
organisms (Figure 4.2). Additional potential paralogs of dPsc were found in 
Drosophila through the algorithm. These proteins are Su(z)2 and l(3)-73Ah; 
however as they are not well characterized as functional Psc homologs, they 
have been excluded these proteins from the phylogenetic tree.  Sequence 
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alignments in Figure 4.3 were constructed using the Emboss program and 
CEC-1 was predicted as a putative Polycomb homolog because of its high 
sequence similarity with Drosophila and mouse Cbx8 chromodomains.  Two 
stretches of amino acids within the N-terminus and C-terminus of CEC-1 also 
shared a strong sequence similarity with the Drosophila and mouse Cbx8 Pc 
boxes. In Figure 4.2, the ClustalW program was used to create a multiple 
sequence alignment of Cbx proteins and subsequently fed into the PHYLIP 
software program (Felsenstein 2008).  The protdist and neighbor joining 
programs within PHYLIP were used to construct the Cbx paralog tree 
(Figure 4.3) and the Emboss local alignment program was used to 




























Figure 4.1: Domain and motif structure of selected PRC1 proteins 
Comparison of domain and motif structure of selected PRC1 proteins in Drosophila (boxed), 
human, mouse, dog, chicken, zebrafish, frog, nematode and sea urchin. Protein lengths are 
scaled exclusively within homolog groups, not among paralog groups, and are represented 
by a black line. Numbers shown above domains are percentage similarity to the domain in 
the Drosophila homolog. Numbers to the right of proteins represent percentage similarity to 
the full-length Drosophila sequence and the number of amino acids in the protein. Note the 
high percentage similarity between domains, but low percentage similarity of full-length 
sequence, between the Drosophila protein and its homologs in other organisms. Also note 
different amino acid lengths of paralog groups (e.g. Cbx4 versus Cbx7) and different domain 
structure (e.g. Cbx2 versus Cbx4). See text for details. Pc homologs are grouped based on 
their sequence similarity to mouse Cbx2, Cbx4, Cbx6, Cbx7 and Cbx8. Putative C. elegans 
Pc protein is shown at bottom (CEC-1). Psc homologs are grouped based on their sequence 
similarity to mouse Bmi1 and Mel-18. Homologs of dRing are grouped based on their 
sequence similarity to mouse Ring1A and Ring1B. Sea urchin Ring is equally similar to 
mouse Ring1A and Ring1B, and is listed separately at the bottom. Abbreviations: c, chicken; 
d, dog; h, human; m, mouse; n, nematode; s, sea urchin; xl, frog; z, zebrafish. Image 



























Figure 4.2: Domain and motif structure of selected PRC2 proteins.  
Comparison of domain and motif structure of selected PRC2 proteins; see 4.1 for details. 
E(z) homologs are grouped based on their sequence similarity to mouse Ezh1 and Ezh2. 
Arabidopsis E(z) homologs are listed separately on the right. Abbreviations: a, plant; c, 
chicken; d, dog; h, human; m, mouse; s, sea urchin; xl, frog; z, zebrafish. Image directly 







Results indicate that: vertebrate model organisms have between three and 
five Pc homologs [known as Chromobox (Cbx)], which all have highly 
conserved CDs and Pc boxes (Figures 4.1, 4.2).  However, paralogs differ 
greatly in length, such as Cbx7 with a protein length of approximately 200 
amino acids; these factors might contribute to differential function (Figures 
4.1, 4.2).  Cbx proteins also specifically interact with non-PcG proteins. 
Cbx4 is the only member of the family that binds the transcriptional co-
repressor C-terminal binding protein (CtBP) (Sewalt, Gunster et al. 1999). 
Cbx4 is also unique among Pc homologs as an E3 SUMO ligase (Kagey, 
Melhuish et al. 2003).  The full range of Cbx4 SUMO targets is unknown, but 
the sumoylation of several transcriptional regulators, including CtBP, is 
enhanced by Cbx4 (Kagey, Melhuish et al. 2003), (Roscic, Moller et al. 
2006).  Additionally, recent biochemical data suggest that the five 
mammalian Cbx proteins have different histone-binding preferences: the 
Cbx CDs bind differentially to H3K27me3 and H3K9me3, unlike Drosophila Pc 
CD, which prefers H3K27me3 (Bernstein, Duncan et al. 2006). 
Psc homologs 
Mel-18 and Bmi1 (two of six Psc homologs in mammals; Figure 4.2) are 
also likely to be non-redundant paralogs, despite their 63% amino acid 
sequence identity. These proteins overall have a low sequence similarity to 
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their Drosophila Psc homolog (12%).  Bmi1- and Mel-18-deficient mice 
display similar but distinct phenotypes (Akasaka, Kanno et al. 1996) and 
(van der Lugt, Domen et al. 1994), and only 30% of Bmi1-regulated genes 
were found to be co-regulated by Mel-18 and vice-versa (Wiederschain, 
Chen et al. 2007).  Interestingly, sea urchin does not have a serine-proline 
rich domain.  
dRing homologs 
Vertebrate homologs of dRing, Ring1A and Ring1B, also exhibit some 
functional divergence (Figure 4.2).  Although they share long stretches of 
high conservation (approximately 100%), Ring1A- and Ring1B-deficient mice 
have drastically different phenotypes (Madireddi, Coyne et al. 1996).  
E(z) homologs 
The mammalian organisms that I focused on have two E(z) homologs: Ezh1 
and Ezh2 (Figures 4.1, 4.2).  Little is known about the functional 
differences between these paralogs in mammals, but the ancestral E(z) gene 
also expanded in plant lineages (Figure 4.1). Arabidopsis has three E(z) 
homologs: MEDEA (MEA), CURLY LEAF (CLF), and SWINGER (SWN) with 
largely non-overlapping patterns of expression (Goodrich, Puangsomlee et 
al. 1997).  CLF is the only protein among Arabidopsis that does not contain 
an E(z) domain. 
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Vertebrates vs. Invertebrate Evolution 
A common mechanism of evolution is gene duplication and subsequent 
divergence of coding sequences or regulatory elements.  Based on the 
bioinformatics analysis, PcG genes are likely to have undergone multiple 
duplication events in their evolutionary history (Figure 4.2).  Perhaps the 
most dynamic period was during the evolution of vertebrates from 
invertebrate ancestors.  The extant invertebrates, Drosophila and sea urchin 
have single copies of the PcG proteins in the reference set, with the 
exception of Psc (Figures 4.1, 4.2).  By contrast, vertebrate species have 
multiple paralogs of most PcG members (Figure 4.2). One striking example 
of PcG expansion is the Pc family.  Represented by a single gene in 
invertebrates, there are up to five Pc homologs in vertebrates with 
differences in domain structure and biochemical properties (see below; 














Figure 4.3: Phylogenetic representation of selected organisms and their PcG 
homologs.  
A phylogenetic tree of selected model organisms from plants to humans is shown (adapted 
from http://www.tolweb.org/tree/). This tree illustrates that PcG-encoding genes have 
undergone multiple duplication events through evolution; the most dynamic period appears 
to be during the evolution of vertebrates from invertebrates. PRC1 components seem to 
have been lost in C. elegans. However, CEC-1 might be a functional PRC1 homolog (see text 
for details). Drosophila proteins, used (here and in the text) as the PcG reference set, are 
highlighted in the red box. Shaded boxes next to each organism display homologs of E(z) 
(red), Pc (orange), Psc (blue) and dRing (green) proteins in each organism. Red slash 
marks represent probable gene expansion events. The black and grey nodes represent the 
common ancestor of all selected model organisms and extant bilateral animals, respectively. 
The light blue and dark blue nodes denote the common ancestor of extant vertebrate and 
mammalian species, respectively. Parentheses denote proteins with biochemically or 
genetically defined PcG activity but lacking sufficient sequence conservation with the 
Drosophila, mouse or human proteins to be predicted as homologs by methods used. 
Brackets indicate putative PcG proteins that were identified by sequence similarity but that 
need to be confirmed functionally. Asterisks represent proteins that might have multiple 
(putative) paralogs within a given organism. Note that branch lengths do not represent 













Prediction of a putative Pc gene in C. elegans 
My analysis uncovered a putative Pc homolog in C. elegans, previously 
identified as C. elegans chromobox 1 (CEC-1) (Agostoni, Albertson et al. 
1996).  Little is known about CEC-1 except that it localizes exclusively to 
somatic nuclei and dissociates from chromosomes at mitosis (Agostoni, 
Albertson et al. 1996).  The domain structure of CEC-1 supports its 
classification as a Pc homolog: an N-terminal CD and a C-terminal Pc box (as 
well as a second putative Pc box after the CD) (Figures 4.1,4.3).  Although 
the sequence similarity between full-length CEC-1 and dPc or dHP1 are equal 
(27%), CEC-1 lacks two important sequence characteristics of HP1 proteins: 
a chromo-shadow domain and a stretch of glutamic acid residues N-terminal 
of the CD (Figure 4.3).  The possibility that CEC-1 might regulate 
H3K27me-dependent gene repression in the worm soma is intriguing but 















Figure 4.4: CEC-1 sequence alignment and phylogeny of mouse Cbx proteins.  
A. Sequence alignment is shown between the chromodomains (CD) and Pc boxes of dPc, 
mouse Cbx8 and CEC-1 proteins. An asterisk represents aromatic residues within the 
chromodomains that are required for histone methyllysine binding. Pc-box-like features are 
found in both the N-terminal and C-terminal regions of CEC-1 and are aligned individually to 
the Pc boxes of dPc and mouse Cbx8. (N) and (C) represent the N-terminal and C-terminal 
Pc-box-like features of CEC-1, respectively. Amino acids highlighted in red represent 
residues that are identical to each other, and those highlighted in blue represent residues 
that are evolutionarily similar. Overall, the bioinformatics analysis suggests that CEC-1 
might represent a Pc homolog, rather than a HP1 homolog. However, this remains to be 
rigorously tested.  
B. Pairwise sequence similarities were calculated between all mouse Pc proteins (Cbx 2, 
Cbx4 and Cbx6–Cbx8) and an unrooted neighbor-joining tree was constructed using the 
PHYLIP software program (http://evolution.genetics.washington.edu/phylip.html). 
Evolutionary distance between paralogs is represented by the tree branches, which are 
drawn to scale. The table below shows percentage sequence identity and percentage 
sequence similarity between the chromodomains, Pc boxes and the full length sequences of 
Cbx2 and Cbx8 proteins. These proteins were selected for comparison because of their 
comparable length and evolutionary distance. Note the high similarity and identity between 

















Predicting chromatin–associated effector proteins 
Chapter 2 illustrates how acetylation has shown to be important for cellular 
function, and why being able to predict and map these marks is an essential 
first step in the discovery process of higher level regulatory pathways.  Of 
paramount importance is the ability to uncover effector proteins that bind 
PTMs, as they serve as another layer of regulation in many cellular 
processes.  Examples of additional effector proteins that bind to post-
translationally modified amino acids are Plant Homeo Domain (PHD) finger,  
bromodomains (BD) (acetyl-lysine binding), chromodomains (CD) (methyl-
lysine binding), and Src-homology 2 (SH2) domains (phospho-tyrosine 
binding), all which have been studied thoroughly.  However, there likely 
exist a number of unidentified proteins containing cryptic versions of these 
domains or similar domains that have eluded detection by conventional 
bioinformatic analysis, thus additional studies of effector domains are 
required to identify these proteins and their functional relevance.  
My interest in this project developed as a result of Allis lab colleagues 
and I extensively using the SMART/PFAM (Bateman, Coin et al. 2004) 
domain prediction programs and recognizing that certain domains that we 
considered as putative effectors by sequence/structure-gazing were not 
contained in either the SMART/PFAM databases, for example p300, a lysine 
acetyltransferase (personal communication, A. Ruthenburg) containing a 
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putative PHD finger domain.  Manual screening of effector proteins that were 
not predicted by PFAM/Smart, together with domain querying of PcG 
proteins with limited results, led us to invest in a project aimed at 
discovering additional effector proteins. 
I hypothesized that software programs such as SMART and PFAM were 
often limited in their domain predictive ability due to default parameters 
usage in within all features of the protein.  For example, loop structure, 
although more flexible than other regions a protein fold, such as the α-helix, 
or β-strand, obtains an identical gap penalty score as the other structured 
elements of the protein.  A tight conservation between loops within an 
alignment is less essential than conservation between the structured regions 
of the protein, since the binding pocket frequently resides on the surface of 
the protein ensconced within well-ordered secondary structural motifs.  
Moreover, gap penalties contribute to the overall score of alignments, and 
therefore, the size of the gap penalty relative to the entries affects the 
alignment that is finally selected.  Though previous bionformatic/structural 
studies have used a similar loop adjustment method in protein finding 
analyses (Qiu and Elber 2006), I wanted to focus on applying this method to 
PTM effector proteins for the benefit of our lab and the chromatin community 




Training set, key assumptions, and method   
In order to begin my computational analysis, I collected all sequences of 
known effector proteins BD, CD, SH2, and PHD finger containing sequences 
found in the SMART database. The SMART database contains more than 500 
domain families found in signaling, extracellular and chromatin-associated 
proteins.  These domains are extensively annotated with respect to phyletic 
distributions, functional class, tertiary structures and functionally important 
residues. The number of human training sequences in each of these 
respective domains was: BD (99), CD (70), SH2 (192), and PHD (256). I 
next performed a multiple sequence alignment (ClustalW) on all training 
sequences through three step process (Figure 4.5):  1) I used JPred, a 
secondary structure prediction program (built from a consensus of multiple 
prediction methods) (Cuff, Clamp et al. 1998) in order to label the loop 
element(s) in my sequences. 2) Applied a less rigid gap penalty exclusively 
in the loop region of protein, while applying a  harsher penalty ( default 
PFAM parameters ) on the more rigid areas 3) Apply the same gap penalty 
to the entire length of the proteins in the alignment.  Next, I fed the loop-
adjusted and unadjusted version of the sequence alignment into the Hidden 
Markov Model 2.0 (HMM), a statistical model in which the system being 
modeled is assumed to be a Markov process with unobserved state.  
Running the HMM against MSA resulted in an output of additional effector 
proteins with an accompanying E-value.  The resulting alignment is the 
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alignment between the consensus sequence which is derived from highest 
residue frequency at each position in the MSA and the predicted effector 
domain.   Based on PFAM’s threshold of selection, the E-value is the number 
of hits that would be expected to have a score equal or better than this by 
chance alone.  A good E-value is much lower than 1, and measures 
statistical significance. In my analysis, I used an E-value <= .01 to threshold 
my boundary. After running my model against the human proteome, I 
manually scanned the list of proteins that were not annotated in literature 
with the desired domain, but which contained a maximum number of 
residues that were critical annotated for PTM binding. As a final step of 
verification, and work which is in progress, I analyze the known structures of 
the predicted effectors in order to ensure sure that the predicted effectors 



















Figure 4.5: Schematic of domain prediction method  
Proteins with known effector domains (chromodomain, bromodomain, etc.) are separated 
by their secondary structure elements such as helix, loop, and beta strand. Loops within the 
proteins are given a less stringent gap penalty than the highly conserved regions in the 
protein such as the helix within the multiple sequence alignment. The alignment is fed into a 
Hidden Markov model (HMM) and then subsequently, the HMM produces an output of 







Via my method, I was able to predict additional effector proteins 
containing all the domains I have specified above.  I compiled a list of 7 
putative candidates in the human and S. cerevisiae proteomes that contain 
previously unannotated BDs, CDs, PHD fingers, or SH2 domains, respectively 
(shown in figures below).  Capital letters in the alignment represent 
residues that are aligned to the consensus.  Small letters represent residues 
that HMM arbitrarily assigns based on a probabilistic function of residues in 
the alignment.  For validation purposes, I used the few literature validated 
effector proteins that were excluded from my training set to assess whether 
my method was promising, particularly for PHD predictions. 
PHD finger predictions  
At the time of my analysis, several of my predicted PHD finger proteins were 
not annotated in literature as PHD finger containing proteins, but have now 
been experimentally validated, and published. These include DNMT3 (Ooi, 
Qiu et al. 2007), RAG2 (Matthews, Kuo et al. 2007), ATRX (Baker, Allis et al. 
2008) and others.  In some cases the PHD finger domains appeared atypical 
by amino acid sequence, particularly for RAG2, which has an atypical 
aromatic cage, and an extremely divergent loop region (Figure 1.7B).  In 
the case of RAG2, I achieved an E value of 0.5 before loop adjustment, and 
an E value of 10e-12 after loop adjustment, which is much lower and of 
higher statistical significance.  My finding is consistent with the finding that 
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RAG2 PHD finger behaves like a canonical H3K4me3 effector (Matthews, Kuo 
et al. 2007). Figure 4.6 displays the alignment between the consensus HMM 
sequence (see Methods for determination) and the novel predicted PHD 
finger sequences (EP300, SNF2), those that are currently not in the 
database.  Aromatic cage residues are highlighted as these are H3K4me3 
recognition residues, as well zinc- coordinating residues. Interestingly, many 
of the predicted PHD finger proteins also contained bromodomains (shown 
below the alignment of the proteins in Figure 4.6).  
Bromodomains 
In humans, I predicted two BD containing proteins, MLL2 and SP110 and in 
yeast I predicted Arp8, an actin related protein involved in chromatin 
remodeling (Figure 4.6).  Among all of these, a promising bromodomain 
candidate protein was Arp8 (E-value=0.01) (Figure 4.6).  This was also a 
compelling candidate because it was a yeast protein, where experiments 
could be facilitated by commercially available strains.  Intriguingly, it also 
contained an important asparigine residue in a conserved histone binding 
acetyl-lysine position (in red).  To determine whether the predicted BD in 
Arp8 could bind to acetylated lysine, I performed a yeast peptide-pulldown 
experiment using a commercially available tap-tagged strain of Arp8.  The 
preliminary experiment shown in Figure 4.7B suggests that Arp8 binds 
selectively to acetyl peptides H3K4me3K14ac and H3K4me3K9ac, but not to 
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H3K56ac.  Next, I cloned and recombinantly expressed full length Arp8 to 
determine whether Arp8 itself, or a possible complex member was 
responsible for peptide binding (data not shown).  I was successfully able to 
achieve cloning of full length Arp8, however further experiments would be 
required to complete the experiment by cloning the bromodomain itself, and 
then subsequently repeating the peptide binding assay using additional 
unmodified and acetyl peptides.    
Chromodomains 
The next group of proteins that I predicted are CD-containing proteins, a 
family containing different subgroups classes of proteins.  The first class 
includes proteins having an N-terminal chromo domain followed by a region 
termed the chromo shadow domain, eg. Drosophila and human 
heterochromatin protein Su(var)205 (HP1).  The second class includes 
proteins with a single chromo domain, eg. Drosophila protein Polycomb (Pc); 
mammalian modifier 3; human Mi-2 autoantigen and several yeast and 
C.elegans hypothetical proteins.  In the third class, paired tandem chromo 
domains are found, eg. in mammalian DNA-binding/helicase proteins CHD-1 
to CHD-4 and yeast protein CHD1.  The training set included a conflation of 
all the CDs found in PFAM, and were not separated individually by family. I 
found two candidates (SMRC1 and MRG1), with the most promising 
predicted candidate, SMRC1, which appears most similar to the 
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chromodomain protein Cbx2 (E =5.3e-7) among all other CD containing 
proteins in the training set.  Also, SMRC1’s sequence similarity to is HP1 (E= 
5e-6), which is also statistically significant.      
SH2 
SH2 domains are modules of ~100 amino acids that bind to specific 
phospho-tyrosine (pY)-containing peptide motifs.  In yeast, the only known 
protein with a SH2 domain is SPT6, a transcriptional elongation protein. 
However, there is no known function associated with the SH2 domain.  My 
analysis led me to discover a SH2 domain containing protein, Ste6, a mating 

































Figure 4.6: Effector Protein Predictions 
An alignment is shown between the consensus domain sequence and the predicted effector 
protein. Domain predictions displayed are the following: PHD, CD, BD, and SH2.  Residues 
that are identical between sequences are shown. Underlined residues are those that are 
critical for histone binding.  E value is shown for the predicted proteins as well as the 
residue positions in the predicted protein. Capital letters in the consensus sequence show 
that this residue is highly conserved, whereas the small letters represent residues that have 
been inserted via probabilistic method. Sequence similarity and identity (%) between the 
consensus and predicted protein is shown in the red box. Shown below alignment are the 













































Figure 4.7: Peptide binding assay using Arp8 whole cell extract.  
A. Schematic of a peptide pulldown assay. The peptide is shown with either an acetylated 
mark or as unmodified. When incubated with Arp8, the question is whether binding occurs.  
B. Shown are peptides H31-20 unmodified, H31-20 with H3K4Me3, H31-20 with 
K4Me3K9ac, H31-20 with H3K4Me3K14ac, H348-63 with K56 unmodified, and H348-63 with 
K56ac. Pulldown assay was performed with a DALK protein-A antibody and bands represent 




Chapter 4 Discussion  
The phylogenetic tree (Figure 4.2) argues that PcG genes underwent 
multiple duplication events in the evolution of plants and animals.  One 
possibility for this is that these extra genomic copies diverged in sequence 
resulting in differential functions conferring fitness advantages. Here, the 
focus was on PcG gene expansion events, but I suspect that PcG proteins 
were also lost from genomes.  A thorough comparative genomic analysis of 
loss and expansion from genomes can help us delve further into which genes 
were deleted through mechanisms of translocation or chromosomal 
inversion. 
An outstanding question in the Polycomb/trithorax field is how these 
transcriptional regulator complexes are localized to specific genes in a tissue 
specific manner.  In Drosophila, DNA elements known as PRE/TREs 
(Polycomb/trithorax response elements) have been mapped near the TSS of 
a handful of PcG/trxG target genes, and have been shown to be essential for 
proper PcG/trxG localization and expression of these genes.  Attempts have 
been made to discover and map functional PRE/TREs in Drosophila using 
genomic, microarray, ChIP, and bioinformatic techniques.  These studies 
identified a total of 167 novel PRE/TREs, some of which mapped to genes 




Unfortunately, the sequence characteristics of putative PRE/TREs in 
mammals have remained elusive.  However, new technology such as ChIP 
coupled to Solexa sequencing has produced large, genome wide data sets 
relating to PcG occupancy and target gene expression.  I present an 
extension of the Ringrose study that I propose in order to predict PREs in the 
human genome (Ringrose, Rehmsmeier et al. 2003).  A brief outline of this 
is as follows: (1) use the current Drosophila annotated PRE data (167 
sequences) to create a computational model for training purposes. Utilize 
empirical methods (supervised or unsupervised clustering) to learn about 
sequence constitution of known PRE elements.  There could be multiple 
methods, but training and testing on the 167 elements themselves (using 
cross validation) could be an initial pilot to assess baseline accuracy. (2) Run 
the algorithm against the mammalian genome and make high quality 
predictions that can be tested in-vivo. (3) Perform ChIP experiments with 
PcG antibodies, and/or mine datasets already published to validate target 
DNA elements.  It would be interesting to observe if validated mammalian 
PRE/TRE map to promoter regions as Ringrose and others observed in 
Drosophila.  Identifying mammalian DNA elements necessary for PcG/trxG 
localization, if they indeed exist, would be an important step towards 





Unmodified H3K4me0 vs. H3K4me Effectors  
Several papers have recently shown PHD finger-containing proteins binding 
H3K4me0.  Recent studies display that DNMT3L, BHC80, TAF3, and AIRE 
among others bind H3K4me0 (Lan, Collins et al. 2007; Ooi, Qiu et al. 2007; 
Koh, Kuo et al. 2008; van Ingen, van Schaik et al. 2008).  Co-crystal 
structures of these proteins with the H3 tail reveal crucial residues mediating 
this recognition.  For example, the basis for binding of H3me0 to DNMT3L is 
the steric occlusion of the aspartic acid 90 in DNMT3L and H3K4me2/3 
(Figure 4.8A).  Other studies have revealed that the salt bridge between 
the unmodified lysine on H3 and acidic residues on the effector are crucial 
for favorable enthalpic contributions to binding free energy.  Recently, the 
Yang Shi and Xiodong Cheng’s groups showed that substrate specificity of 
the BHC80 PHD finger is determined primarily through the recognition of the 
H3 amino terminus, H3K4 and H3R8, and the three main chain carbonyl 
oxygen atoms (residues 523, 524 and 525) on BHC80 that form a hydrogen 
bond ‘cage’ that recognizes the N terminus of H3 (Lan, Collins et al. 2007).  
Molecular recognition of the unmodified lysine is primarily through bonds to 
the unmodified epsilon amino group and steric exclusion of appended methyl 
groups, where a second or third methyl group would engender steric clashes 
with the D489 carboxylate, the amide carbonyl of E488, and the β-carbon of 
the H487 side chain (van Ingen, van Schaik et al. 2008).  Additional motifs 
include a Proline-(x)-Glycine -x - Tryptophan motif before the last pair of 
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Cysteines (Figure 4.8B in blue, c-terminal). Figure 4.8 is an alignment of 
the current list of H3K4me0 binders.  
In order to predict additional effectors using my method, I use the 
training method described above to predict new unmodified H3K4 binders, 
and use the known H3K4me0 as my training set of sequences (Figure 
4.8B).  Even though the training set is small (only five sequences), there 
are a number of conserved residues in these proteins, and for further 
screening of H3K4me0 binders, I manually scanned for proteins with these 
residues in the conserved positions.  In my list (Figure 4.8C), many of the 
predicted proteins are either published or are being worked on by other 
groups, such as DNMT3, JARID1A, and AIRE (Ooi, Qiu et al. 2007; Koh, Kuo 
et al. 2008; Wang, Song et al. 2009).  The published list of proteins gives 
me confidence that using more sophisticated methods, additional effectors 




























Figure 4.8: H3K4Me0 Known and Putative Effectors  
A. (Left) Interaction between the H3 N terminus (amino acids in magenta) and DNMT3L (in 
black). Dashed lines indicate potential interactions between amino-acid side chains. H3K4 
makes contacts with DNMT3L. D90 and D88 and methylation of K4 will occlude these 
interactions. (Right) Mutagenesis of residues (tick marks on left) of DNMT3L abolished 
binding. Image adapted from (Ooi, Qiu et al. 2007). 
B. Alignment of all known H3K4Me0 binding proteins. Yellow represents identical residues; 
blue represents similar patches of residues. Alignment constructed using ClustalW.  
C. Predicted H3K4me0 binders (gi annotation to the left) with E-value resulting from Hidden 

























Taken together, the studies I performed in this chapter reveal that 
there are still a number of undiscovered protein domains.  Improved 
algorithms, more accurate prediction modeling, and higher throughput 
evolutionary analysis can benefit multi-domain classification problems, and 
































Chapter 5: General Discussion  
A rapidly growing literature suggests that acetylation in histone and 
nonhistone proteins is important for a number of biological processes, 
including cellular differentiation, DNA binding, and other chromatin-
templated processes.  In the previous chapters, I have discussed my work 
developing a computational model that will enable the scientific community 
to characterize and map putative acetylation sites in any protein of interest. 
I have also shown using my model that we can predict acetylation sites in 
both histone and nonhistone proteins.  Furthermore, I have shown that there 
are potentially key residues that are essential for acetyltransferase 
recognition, and that acetyltransferase activity might be regulated via 
crosstalk between modifications on the H3 tail.  My computational model and 
results represent a step towards gaining a framework for predicting lysine 
acetylation sites in both human and yeast proteomes.  It will be of interest in 
future studies to see whether our algorithm is capable of predicting lysine 
acetylation sites in other organisms. Below I will discuss some of the 






Enzyme prediction and discovery 
Elegant structural studies by the Marmorstein group have shown that 
specific residues within KATs (Gcn5, Esa1) that form contacts between the 
enzyme and substrate are conserved among organisms (Marmorstein and 
Roth 2001).  My algorithm agrees with the importance of these conserved 
residues, yet I was limited by the quantity of structural information 
available.  Further structural analysis of various KAT-substrate relationships 
would allow us to determine whether the rules that we have observed are 
general acetyltransferase rules or enzyme specific principles. However, 
structural studies remain experimentally challenging and low-throughput by 
nature. 
Alternatively, my prediction algorithm might be improved through 
additional experimental determination of KAT-substrate specificity, this in 
turn leading to an improved training dataset.  To achieve a deeper 
understanding of KAT enzymes and their substrate specificity proteome-
wide, I could perform the following experiments: first, on a small scale to 
establish the assay, and then-genome wide, I would design two identical 
proteome arrays containing histones H3, H4, and bovine serum albumin 
(BSA) as a negative control.  Each array would then be incubated with 
radiolabeled acetyl-CoA and either of the histone acetyltransferases Gcn5 or 
Esa1, respectively.  The array would then be subjected to fluorography, and 
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a positive result would entail Gcn5 labeling H3, and Esa1 labeling H4 
(Figure 5.1A).  I would not expect to see a signal in the BSA lane. If my 
pilot arrays confirm the expected results, I could carry out this experiment 
on a proteome-wide scale.   
Further testing on magnified scale would involve protein microarrays 
containing 5800 yeast proteins incubated individually with all known yeast 
HATs (currently there are seven). Detection of incorporated radiolabeled 
acetyl-CoA would result in a number of possible KAT substrates.  These 
substrates would then be validated from individually TAP-tagged lines. First, 
all acetylated proteins would be immunoprecipitated (IP) using a monoclonal 
pan-acetyl-lysine antibody (there are several commercially available).  The 
presence of the potential HAT substrate would then be probed by 
immunoblotting with an anti-TAP antibody.  Mass spectrometry would then 
be used to map the position of the acetylated lysine on the protein.  A 
similar study was published recently by the Shelley Berger lab revealing 
NuA4’s substrate specificity (Krishnamoorthy, Chen et al. 2006) (Figure 
5.1B).  A follow-up gene ontology (GO) analysis could indicate pathways or 




















Figure 5.1: Proposed discovery of novel KAT substrates 
A. Proteome-wide microarray of enzymatic discovery of substrates. In step 1, develop pilot 
protein array with H3 and H4 on the array.  Incubate array with Gcn5 and Esa1. Once 
controls have been tested, include all 5800 proteins per array, and incubate array with each 
enzyme separately. Black boxes represent putative acetylated proteins as result of this 
assay, which become candidate substrates.  An immunoprecipitation of substrates with pan-
acetyl antibody followed by a TAP tag purification and subsequent MS/MS analysis could be 
performed to map the acetyl site.   
B. Example of an array which includes 5800 proteins on an array. Acetylated substrates that 
were detected were Pck and Cdc34 among others (Lin, Lu et al. 2009).  
C. Proposed computational model. Substrates with identical enzyme could potentially cluster 













The results of these experiments could allow me to add enzymatic 
information onto the hierarchical tree (Figure 2.2), which could add 
predictive power to my algorithm. Potentially, these results would help 
uncover enzyme specificity for nonhistone acetyl substrates. I would expect 
substrates of the same KAT to cluster in my analysis, therefore if a substrate 
of an unknown HAT clusters tightly with a substrate of known HAT activity, I 
would expect these two to be substrates of the same HAT.  This procedure 
could help narrow down whether there are specific clusters designated by 
enzyme, or whether there are acetylation rules in general, so that we can 
gain a further predictive understanding of our targets (Figure 5.1C).  
Furthermore, this experiment would allow me to gain insight into residues 
that are critical for specific enzyme recognition, which could ultimately feed 
back into the algorithm by changing the weight function of flanking residues.   
142 
 
In Chapter 3, I discussed my aim to induce methylation on H3K14 by 
mutagenizing residues in vivo to emulate the flanking residue profile of 
H3K36, a famous di and tri-methyl site.  However, little is known about 
methyltransferase specificity and enzyme recognition.  My initial 
computational analysis of methylation substrates displayed that a strong 
consensus sequence or signal was not present among the flanking residues 
of methyl-lysines, possibly due to limited experimental data.  This could be 
due to the fact that methyltransferases have different selectivity 
mechanisms and that we may be underfitting the data by studying a 
conflation of these substrates.  Using the same protein microarray as for 
acetylation, methylation could also be studied by incubating the microarrays 
with radiolabeled S-adenosylmethionine (SAM) and various 
methyltransferases. Further computational analysis and more defined 
datasets could allow us to explore methylation rules as well.   
Crosstalk of modifications on the same histone tail domain  
 To my knowledge thus far, there have been few studies that have rigorously 
computationally or experimentally tested the necessity of specific flanking 
residues in maintenance of an acetyl mark.  My results in Chapter 3 
demonstrate that the flanking residue mutations of H3K14 can initiate   
crosstalk that can potentially occur between modifications on the same tail. 
It has been previously shown that acetylation of a particular lysine can be 
inhibited by adjacent PTMs (negative crosstalk), with the implication that the 
responsible KAT might be prevented from binding to or accessing its target 
site (Yang and Seto 2008).  My mutagenesis studies on the flanking residues 
of H3K14 suggested that there could be a longer range crosstalk occurring 
between H3K14, H3K9, and H3K36, and perhaps these modifications are 
inhibitory to each other in some manner. Briefly, I observed that upon 
mutation of H3A15 to a lysine, H3K14ac levels decreased approximately 4 
fold, while H3K9ac levels increased by two fold. H3K36me0 and H3K36me1 
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levels soared, while H3K36me2 and H3K36me3 decreased by approximately 
1.5-2 fold.   
To further study whether the lysine A15 is an enzyme specific residue, 
I could perform the experiment in reverse: select a lysine that is low in 
abundance and then mutate the “next door” residue to an alanine to 
determine whether the target residue acetylation levels are stimulated.   An 
ideal lysine for this experiment would be H3K36, since it is of low abundance 
in yeast (Morris, Rao et al. 2007), and has a lysine (K37) adjacently 
positioned.  Thereafter, I would extract histones as I previously did, and 
analyze their PTM levels by mass spectrometry.  First, I could address 
whether the acetylation of K36 increases in intensity as a result of this 
mutation, and whether H3K37 is also modified (Figure 5.2B,C).  Perhaps an 
altered acetylation state of H3K36 would recruit an enzymatic complex which 
could stimulate H3K37 acetylation or methylation states.  Second,  it would 
be interesting to see whether H3K9ac, H3K14ac, or any of the H3K36me0, 
me1, me2, and me3 marks are affected by the K37A mutation, since 
crosstalk has been shown to occur previously on histone tails (Latham and 
Dent 2007).   Perhaps a rise in H3K36ac levels would prevent methylation to 
occur on H3K36 (Figure 5.2C), and H3K37A would carry a similar profile to 
H3A15K (Figure 5.2C) (Latham and Dent 2007).  Another related question 
that could be asked is whether mutations in the flanking residues of H3K14 
and H3K36 would alter transcriptional profiles genome-wide since all three 
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marks, H3K9ac, K14ac, and K36me have a link to transcriptional activation 
(Kurdistani, Tavazoie et al. 2004).  My finding suggests that there might be 
a distinctive role for each acetylation, and it is now possible to examine the 



































Figure 5.2: Proposed future mutagenesis of H3K36 
A. Sequence alignment of H3K14 and H3K36. Colors as in Figure 3.3. 
B. Proposed mutation of H3K37 to an alanine.  
C. Proposed cross-talk effect of H3K37A mutation. H3K36 acetylation levels could increase, 
which could cause H3K36 methylation to decrease. H3K36 effects could regulate H3K14ac, 

























Histone variants and PTMs   
Changes in the chromatin template can occur through various interrelated 
mechanisms: post-translational modifications of histones, ATP-dependent 
chromatin remodeling, and the incorporation (or replacement) of specialized 
histone variants into chromatin (Bernstein and Hake 2006). These variants 
have specialized functions and in some cases are synthesized through the 
cell cycle (Bernstein and Hake 2006).  While the two major human histone 
variants of H3, CENP-A and H3.3, have been extensively studied, the larger 
number of human H2A variants, including H2A.Z, H2A.X, and others, has 
been studied relatively less.  There are at present three testis-specific H2B 
variants, and to date, no variants from the H4 family have been uncovered 
(Bernstein and Hake 2006) (Figure 5.3, courtesy Sandra B. Hake). 
Since many variants have specialized functions and unique sequences, 
PTM profiles of these variants would potentially help gain a mechanistic 
insight into variant function.  For example, phosphorylation on the serine in 
the H2A.X motif “SQ(E/D)” upon DNA damage is a phenomenon which is 
conserved across species (Rogakou, Pilch et al. 1998; Downs, Lowndes et al. 
2000; Stiff, O'Driscoll et al. 2004; Xiao, Li et al. 2009).  Predicting additional 
modifications on these proteins might help unravel further distinct regulatory 
functions or pathways.  I attempted to predict modification patterns on H3 
variants, however, as H3 variants are dissimilar to the canonical H3 by only 
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four or five amino acids, as shown in the alignment, the algorithm did not 
predict any additional modifications on this variant.   
Human histone variants have been studied relatively in depth, 
however yeast histone variants are still an area that has not been as 
intensely explored.  When I ran the yeast variant Cse4 (homolog of human 
CENP-A) against my algorithm, to my surprise, a protein which seems 
dissimilar by “eye” to the canonical H3, had a strong similarity (80%) to 
H3K56 in yeast (Figure 5.4A,B(red arrow)).  Since the enzyme responsible 
for yeast H3K56ac has been discovered (Rtt109/p300) (Tang, Holbert et al. 
2008) and functionally deciphered, Cse4 might also acetylated by similar 
HATs, which would point to a sequence conservation of K56-type substrates.  
If Cse4 is indeed acetylated, one could then perform knockouts of the HATs 
themselves to determine whether Rtt109/p300 is responsible for Cse4 
acetylation. This would also allow one to pinpoint residues that may be 












Figure 5.3: Schematic of mammalian histone variant proteins  
Schematic representation of the mammalian histone variant proteins containing the N-
terminal tails and the globular core with the C-terminal tails: (A) H2A variants (yellow), (B) 
H2B variants (red), (C) H3 variants (blue), (D) H4 variants (green). Protein sequences that 
are highly divergent between the conventional histone and its variants, histones are 
depicted in different color shades without highlighting sequence differences. Specific amino 
acids are depicted when only a few key differences are found among variants, or when 
these amino acids are post-translationally modified. Residues that have been found to be 
post-translationally modified are marked in the following manner: circle, phosphorylation; 
square, methylation; triangle, acetylation; trapezoid, ubiquitination. The macrodomains of 
macroH2A histones are not drawn to scale and are shown as triangles to highlight that 








Figure 5.4: H3K56 and Cse4  
A. Alignment of H3K56 and Cse4 in budding yeast. Yellow highlighted residues represent 
patch of similar residues in a different order in H3K56 vs. Cse4. Purple residue represents 
similar amino acids, whereas red denotes identical residues.   
B. Alignment of all H3 variants, hCENP-A, and yCse4. Arrows indicate H3K56 which is 
conserved across variants, and Cse4K52.   
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In addition to the four core histones, there is a fifth histone, linker 
histone H1, involved in nucleosome structure (Figure 5.5A). These proteins 
are crucial to nucleosome-nucleosome contact and higher order chromatin 
structure.  It is possible that post-translational modifications could regulate 
their contact, causing dramatic chromatin structure changes, including 
decreased global nucleosome spacing, reduced local chromatin compaction, 
and decreases in certain core histone modifications.  A multiple sequence 
alignment of the H1 variants is shown Figure 5.5B, and as displayed these 
variants are conserved in the core region, but divergent within the tail 
region.  To predict additional modifications as well as experimentally 
validated modifications, I ran the yeast and human histone variants 
including H1 against my algorithm.  Interestingly, out of 5 known H1 
validated acetyl sites, I was able to predict 3 with my algorithm (these 
included K90, K146, and K22) (Figure 5.5B; red arrows) (Wisniewski, 
Zougman et al. 2007).  Notably, these acetylation sites all contained a 
flanking glycine and basic residues in the vicinity as well.  Further validation 
of the predicted unknown modifications might lead to an important 
understanding of the role of acetylation in H1 function. Finally, genomic and 
proteomic studies, evolutionary analysis using bioinformatics, and 
experimental approaches in model organisms will provide new insights into 




Figure 5.5: H1 Schematic and Predictions  
A. Nucleosome made up of DNA (red), Histone octamer (black) and Histone H1 (green). 
B. Alignment of all H1 variants, CENP-A, and yCse4. Arrows indicate acetylated lysines 
that I predicted correctly in histone H1.    
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Many questions remain as to whether acetylation, like phosphorylation, is 
a key signaling mechanism for multiple cellular pathways. Mann’s study 
reveals that a striking feature of acetylation is that it tends to occur in large 
macromolecular complexes involved in diverse cellular processes 
(Choudhary, Kumar et al. 2009).  With higher throughput proteomic 
datasets becoming available, we can begin to dissect the role of distinct 
acetylation marks across multiple cell lines and analyze their importance in 
cellular pathways, signaling, and gene regulation.  Answering these 
questions can help us achieve state of the art epigenetic drug therapy 
targeted towards specific acetylation marks, however mapping these marks 
is a critical first step.  Understanding the crosstalk between acetylation and 
other PTMs such as methylation and phosphorylation remains to be 




















Chapter 6: Materials and Methods  
Acetylation (computational)   
Datasets 
Training set: 56 human and S. cerevisiae core histone lysine sequences 
were collected from the Swissprot database http://ca.expasy.org/sprot/. 
Test set: Source of nuclear protein and pan-acetyl antibody datasets are 
described in Chapter 2. The budding yeast proteome-wide dataset of 
observed peptides with acetyl modifications was derived from the publicly 
available GPM Annotated Spectrum Library (Craig, Cortens et al. 2006) for 
S. cerevisiae (v. 2008.10.1). Peptide sequences from the library 
corresponding to lysine modifications (nominal modification mass = 42 Da.) 
were curated and mapped onto the appropriate set of protein sequences. 
Given the mass resolution of many of the spectra used to create the library, 
it was not possible to distinguish a priori between acetyl-lysine versus 
trimethyl-lysine on the basis of the tandem spectra alone.  
Hierarchical Clustering Analysis 
 I performed hierarchical clustering on the sequences surrounding each of 
the 56 histone lysines. All 56 sequences were aligned to each other creating 
a matrix of pairwise alignment scores; the metric was based on these 
pairwise scores. Sequence alignment scores were computed by performing 
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BLAST local alignments using the NCBI BLAST 2.0 server.  A standard 
BLOSOM62 evolutionary substitution matrix was applied (Eddy 2004). The 
hierarchical clustering works in an iterative process with the sequence 
alignment score representing the metric value: it begins with each protein 
sequence as a singleton cluster; during each iteration, it finds two clusters 
with the lowest metric value, then joins these two clusters into a new 
cluster, and updates the metric value between this new cluster and all 
others (see text for details). An average alignment score is calculated when 
there are multiple leaves under a node, thereby assigning a single metric 
value to each node. As an example, H2AK127, a lysine not observed as 
acetylated, and H4K12, an acetylated lysine, clustered tightly via sequence 
alignment. This is illustrated by their shared node placing them to right of 
the threshold line (Figure 2.2A; blue box). As a result, H2AK127 was 
predicted to be acetylated via my approach. In contrast, H2BK27 clustered 
with H2BK11 more weakly, and thus their shared node was positioned on 
the left side of the threshold line. Hence, this lysine H2BK27 was not 
predicted as acetylated. 
Statistical Analysis 
ROC calculations are described in main text. Hypergeometric probability 
calculation: Pr= ; (N = all lysines in human proteome; K = 
number of times the particular residue is seen flanking in each position in 
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human proteome; n = total number of lysines in each independent validation 
dataset; m = number of times the particular residue is seen flanking in each 
position in validation dataset). Sensitivity (Sn) was calculated as the total 
number of correctly identified acetylation sites from the positive dataset 
divided by the total positive dataset. Specificity (Sp) was calculated as the 
total number of negative sites that were not predicted to be acetylated 
divided by the total negative dataset size. Accuracy calculated as the 
number lysines correctly predicted as acetylated/total number of acetylated 
lysines in dataset.  
Additional Methods of Classification 
 When I first began the project, I used a Support Vector Machine Classifier 
(SVM Light) to analyze my data (Yu, Joachims et al. 2008). I used a linear 
kernel function, which measures the similarity between a pair of inputs, and 
defines an inner product in the feature space. My feature space consisted of 
k-mers, where k = (2..6). These k-mers were extracted from the residues 
surrounding the flanking lysine.  The results of this method (75% accuracy 
on histone lysines, where a lysine was either classified as “validated” or “not 
observed” as acetylated) encouraged me to proceed and use additional 
machine learning methods empirically.  Hence,  I also used a mismatch 
kernel (Leslie, Eskin et al. 2004), which consists of a class of string kernels 
for use with support vector machines (SVMs) to measure sequence similarity 
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allowing for mutations between patterns. Thus, if two protein sequences 
contain many k-length subsequences that contain m, mismatches, the inner 
product one would expect is large. The mismatch kernel did not alter my 
results significantly as compared to the linear kernel.  Other types of kernels 
I used were the profile and quadratic kernels, however the best results were 
achieved using the linear and mismatch kernels.   
Weighting 
 As described in Chapter 2, I weighted residues to the left and to the right of 
target lysines within the sequence alignment. The weight was added to the 
raw alignment score such that the Ts= Raw alignment score + ∑wi of each 
identical or evolutionarily similar flanking residue, where Ts = total score, 
and wi = 1/d; d= position of flanking residue with respect to lysine. I also 
grouped chemically similar residues together, such that residues that may 
not be evolutionarily similar according to the BLOSUM matrix, but within the 
same chemical group, such as small, aromatic, hydrophobic, etc. are also 
given weight to.  Using chemical similarity improved the algorithm 
performance by a five to eight percent margin (accuracy measure) for both 
histones and non-histone proteins, and thus I included chemical similarity in 







Sequence logos for displaying the flanking residue distribution of all lysines 
in my training and test datasets were created according to (Crooks, Hon et 
al. 2004). 
Software URL 
The acetylation prediction software, PredMod can be found at 
http://www.cs.cornell.edu/w8/~amrita/predmod.html  
Cross Validation and Evaluation of Test Sets 
I used Leave One out cross Validation (LOV) of histone lysines on the 
training set and performed a ROC analysis. The predictive performance was 
monitored using the AUC metric (Dodd and Pepe 2003) on the test lysines. I 
applied the procedure to 1000 random permutations of the labels of the 
observed and not observed lysines. The independent datasets were also 
measured by a ROC analysis, as described previously. 
Human Nonhistone Analysis Method 
 In order to measure whether the prediction method also works on 
nonhistone lysines, I first applied my algorithm to a list of validated lysine 
acetylation sites in human nonhistone proteins. I used the following two 
independent validation datasets for my analysis: Firstly, a proteomics 
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survey of published cytosolic and nuclear protein fractions from Hela cells 
that were subjected to immunoaffinity purification using a pan-acetyl lysine 
antibody was applied. Isolated peptides were analyzed by HPLC-MS/MS and 
the final output contained 51 acetylated lysines in 38 proteins (Kim, Sprung 
et al. 2006). Secondly, I screened the literature for acetylated proteins and 
found 32 molecules containing 73 acetylated lysines that were reported as 
acetylated both in vitro and/or in vivo using mass spectrometry and 
immunoblotting detection methods. The test data sets were composed of 
lysines that were identified as acetylated and represent my positive set 
(“validated”), and lysines that were not observed as acetylated within these 
investigated substrates represented my negative dataset (“not observed”). 
By comparing validated acetyl marks to my computationally predicted 
acetylation marks, we tested whether sites are dictated by the surrounding 
amino acid sequences to validate my stated assumption that there is an 




 Mammalian cell lines were grown in Iscove's DMEM supplemented with 10% 




Human Histone Purification 
Cell nuclei were isolated by hypotonic lysis in buffer containing 10 mM Tris-
HCl (pH 8.0), 1 mM KCl, 1.5 mM MgCl2, 1 mM DTT, 0.4 mM PMSF, and 
protease and phosphatase inhibitors. Pelleted nuclei were extracted using 
0.4 M sulfuric acid. The acid-soluble histones were precipitated with 
trichloroacetic acid and resuspended in water. Histones were separated by 
reverse phase HPLC using a C8 column (220 by 4.6 mm Aquapore RP-300, 
PerkinElmer Life Sciences) with a linear ascending gradient of 35–60% 
solvent B (solvent A: 5% acetonitrile, 0.1% trifluoroacetic acid, solvent B: 
90% acetonitrile) over 75 min at 1.0 ml/min on a Beckman Coulter System 
Gold 126 Pump Module and 166/168 Detector.  For the additional data that 
was obtained from sodium butyrate treated samples, histones were purified 
from HeLa S3 cells and treated with 10mM sodium butyrate for 15 hmys 
prior to harvesting (STable 6). H3 was also purified from HEK293 cells 
treated with sodium butyrate (see below). 
Mass Spectrometric Analysis of Human Histones H2A and H3 
Histones were isolated and H2A was purified as described previously 
(Shechter, Dormann et al. 2007) from HL60 cells. The HPLC fraction 
containing purified H2A was resuspended in water, and an aliquot was 
diluted with 100 mM ammonium bicarbonate, pH 8.  The diluted aliquot was 
divided in half. One half was digested with GluC protease (Princeton 
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Separations, Inc, Adelphia, NJ) at a substrate-to-enzyme ratio of 20:1 for 4 
h at RT, and glacial acetic acid was used to quench the digest. An aliquot of 
the GluC-digested H2A containing approximately 1 picomole of H2A was 
diluted 3-fold with ammonium bicarbonate to increase the pH to 8.0. H2A 
peptides were then derivatized by treatment with deutero succinimido 
acetate. This reagent was created by adding deutero acetic anhydride and 
triethylamine to N-Hydroxysuccinimide, and the white precipitate was 
collected after rinsing with hexanes. 0.35mg (≈ 2 micromoles) of deutero 
succinimido acetate was added to the H2A peptide mixture, containing an 
estimated 20 picomoles of free amino groups. The deutero-acetylation 
reagent and H2A peptides were allowed to react for 2 h at 4 °C. Deutero-
acetylation of the N-termini of peptides and the epsilon amino groups of 
lysine residues increases the hydrophobicity of the H2A peptides, and allows 
the smaller, hydrophilic peptides of H2A to be retained on a C18 column. 
Instead of adding a 42-Da acetyl group (C2H3O), this reagent adds a 45-Da 
acetyl group (C2D3O) since it contains 3 deuteriums instead of 3 hydrogens. 
Therefore, an in vivo lysine acetylation is distinguished from a deutero-
acetylation because of their difference in mass.  
After performing this reaction, the mixture was acidified with glacial acetic 
acid and loaded onto a capillary precolumn (360 μm O.D. x 75 μm I.D. fused 
silica, Polymicro Technologies, Phoenix, AZ) packed with irregular 5–20 μm 
C18 resin (YMC Inc., Wilmington, NC). The precolumn was then connected to 
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an analytical column packed with regular 5 μm C18 resin equipped with an 
electrospray tip.H2A peptides were separated using nanoflow HPLC on an 
1100 series binary HPLC pump (Agilent Technologies, Palo Alto, CA) coupled 
to a micro-electrospray ionization smyce on a Finnigan LTQ Orbitrap mass 
spectrometer (Thermo Scientific, San Jose, CA) The HPLC gradient consisted 
of 0-60 %B in 50 min and 60-100 %B in 10 min (solvent A: 0.1 M acetic 
acid, solvent B: 70 % acetonitrile, 0.1 M acetic acid), with a flow rate of 60 
nL/min. Full mass spectra were acquired with the Orbitrap as the analyzer, 
and MS/MS spectra were acquired in the LTQ ion trap. After each full MS 
scan, m/z values of 535.6, 537.1, 513.1, 514.6, 534.1, and 511.6 were 
targeted sequentially for isolation and fragmentation. The last scan event in 
the cycle (prior to acquisition of the next full MS scan) was a data-dependent 
MS/MS scan of the most abundant ion in the previously acquired full MS 
scan. MS/MS spectra were manually interpreted. This approach employing 
GluC digestion and deutero-acetylation was used to examine the C-terminal 
H2A peptide, residues 122-129. 
The second half of the H2A aliquot was treated with propionic anhydride to 
derivatize endogenously monomethylated and unmodified epsilon amino 
groups of lysine residues. Chemical derivatization with propionic anhydride 
converts amino groups of lysines to their corresponding propionyl amides 
and has been detailed previously (Garcia, Mollah et al. 2007). Briefly, equal 
volumes of propionylation reagent and protein were reacted, and 
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derivatization was repeated twice to ensure full conversion of amino groups.  
The sample was vacuum-dried after each derivatization. H2A was then 
digested with trypsin (Promega, Madison, WI) at a substrate-to-enzyme 
ratio of 20:1 for 7 h at 37 °C. Derivatization blocks lysine residues from 
cleavage, and thus trypsin cleaves C-terminal to arginine residues only. The 
resulting H2A peptide mixture was acidified with glacial acetic acid and 
loaded onto a reverse phase capillary column for LC-MS/MS analysis as 
described above.  H2A peptides were analyzed using a hybrid quadrupole 
linear ion trap Fourier transform (LTQ-FT) mass spectrometer (Thermo 
Scientific, San Jose, CA). The LTQ-FT instrument was operated in data-
dependent mode with dynamic exclusion enabled. The data-dependent 
method consisted of acquisition of a full scan mass spectrum using the FT as 
analyzer followed by ten MS/MS scans of the ten most abundant ions in the 
initial full scan. MS/MS scans were acquired using the ion trap as the 
analyzer and spectra manually interpreted. This approach employing 
propionylation and trypsin digestion was used to examine N-terminal H2A 
peptides, 4-11 and 12-17. 
Histone H3 was purified as described previously (Garcia, Barber et al. 
2005; Hake, Garcia et al. 2006) from sodium butyrate-treated HEK293 cells.  
H3 was treated with propionic anhydride and digested with trypsin, similar to 
the procedure described for H2A. Following digestion, the samples were 
again reacted with propionic anhydride to derivatize the amino-termini of the 
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trypsin-generated H3 peptides.  The peptide mixture was dried in a speed-
vac concentrator, and subsequently reconstituted in 0.1% acetic acid. H3 
peptides were loaded onto a capillary reverse phase precolumn, and the 
precolumn was connected to an analytical column as described above.  
Peptides were gradient-eluted into an LTQ Orbitrap mass spectrometer 
(Thermo Fisher Scientific, San Jose, CA).  The instrument was operated in 
data dependent mode and cycled through acquisition of a full mass scan 
followed by MS/MS scans of the ten most abundant peptide cations in the 
initial full scan.  This approach was used to examine the N-terminal H3 
peptide, 27-40. All MS/MS spectra were manually interpreted. 
Mass spectrometric analysis of nonhistone lysine acetylation sites  
Tagged cells of my nonhistone proteins were lysed under cryogenic 
conditions. Tandem Tap-tag purification was performed on candidate yeast 
proteins as described (Puig, Caspary et al. 2001) and eluates run on SDS-
PAGE gels and stained with coomassie. Protein bands were in-gel digested 
with trypsin or chymotrypsin, and peptides extracted.  
Each of the protein bands were cut into two pieces with similar size and 
washed with 10% acidic acid in 50% ethanol (acetic acid:ethanol:water = 
10:50:40 (v/v/v)) three times and then overnight.  After destaining three 
times with 25 mM ammonium bicarbonate in ethanol buffer (ethanol:water = 
50:50 (v/v)), the gel bands were swollen in water twice and then cut into 
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small pieces.  They were dehydrated in acetonitrile and then dried in a 
SpeedVac (Thermo electron, Waltham, MA).  Overnight digestion was 
performed at 37 ºC with about 200 ng of modified porcine trypsin (Promega, 
Madison, WI) or chymotrypsin (Roche, Indianapolis, IN) in 50 mM 
ammonium bicarbonate. The resulting peptides were extracted sequentially 
with 5% TFA/50% acetonitrile/45% water (v/v/v), and 0.1% TFA/75% 
acetonitrile/24.9% water (v/v/v), and 100% acetonitrile.  The extracts were 
combined and dried in a SpeedVac. The resulting peptides were cleaned with 
C18 ZipTips (Millipore, Bedford, MA) according to the manufacturer’s 
instructions, prior to nano-HPLC/mass spectrometric analysis. 
The extracted peptides were separated using a capillary HPLC column (11 
mm length × 75 μm I.D., 4 μm particle size, 90 Å pore diameter) packed in-
house with Jupiter C12 resin (Phenomenex, Torrance, CA). LC-MS/MS 
analysis was performed in an integrated system that includes an Agilent 
1100 series nanoflow LC system (Agilent, Palo Alto, CA) and a LTQ 2D trap 
mass spectrometer (Thermo Electron, Waltham, MA) equipped with a 
nanoelectrospray ionization (NSI) smyce.  The gradient-eluted peptides 
were electrosprayed directly into the LTQ mass spectrometer, which was 
operated in a data-dependent mode.  Mascot (version 2.1, Matrix Science, 
London, U.K.) was used for database searching. Acetylated lysine containing 
peptides identified with a Mascot score of 20 or above were manually 
verified by a method described previously (Chen, Kwon et al. 2005). 
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Yeast Strains and Plasmids. 
Strain MSY421 from M. M. Smith (University of Virginia) [MAT a, Δ(hht1-
hhf1) Δ(hht2-hhf2) leu2-3, 112, ura3-62, trp1, his3, pMS329 (HHT1-HHF1, 
URA3, CEN)] was used to shuffle in plasmids containing histone H3 A15K, 
H3G13V, and H3A15V mutations using 5-FOA as a counterselecting agent for 
the URA3 plasmid. The mutant plasmids were generated by PCR 
mutagenesis (H3A15K, H3A15V, H3G13V) and confirmed by sequencing. The 
final yeast strain was confirmed by PCR amplification of the HHT2-HHF2 
locus and DNA sequencing. Yeast growth, plasmid and DNA fragment 
transformation of yeast cells were done according to standard yeast 
protocols (Hieter et al, Methods in Yeast Genetics).  
Extraction of Histones 
Histones were extracted from nuclei made from 1 liter of cells grown to an 
OD600 of 0.8 in yeast-rich media. Nuclei were prepared in the presence of 
protease inhibitors, and histones were obtained by acid extraction as 
described in (Hsu, Sun et al. 2000). One-tenth of each fraction was used to 
confirm the presence of purified histones by SDS/PAGE separation and 





Mass Spectrometry of Yeast Histones 
Histones were prepared using propionic anhydride reagent and digested with 
trypsin as described previously (Garcia, Mollah et al. 2007).  For mass 
spectrometry analysis, histones were loaded on to C18 packed columns and 
separated using an Agilent 1200 series HPLC system (Agilent Technologies), 
and the LC gradient used was 5% B to 45% B over 60 min.  All data was 
acquired on an LTQ-Orbitrap as previously described (Leroy, Toubeau et al. 
2006).      
Domain Prediction (computational)   
I performed the domain prediction analysis by creating a multiple sequence 
alignment of known effector proteins of my domain of interest using the 
software program ClustalW. Sequences that were fed into my MSA were 
based on a concatenated sequence, ie. If the domain consisted of a helix, 
loop, helix, then I ensured that the loop region of the sequence had a lower 
gap penalty, while the helix part of the sequence had a more stringent gap 
penalty (JPred) (Cole, Barber et al. 2008). The MSA was then fed into a 
Hidden Markov Model 2.0 which calculated the probability of the output 
sequence based on a probabilistic weight analysis of input sequences. The 
final result I obtained was an E-value of the statistical significance of my 
prediction given the selected parameters. I compared this value against an 
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unadjusted loop, and so I obtained a list of predictions for the unadjusted 
and adjusted loops.  
PcG domain detection  
I  selected E(z), Pc, dRing and Psc as my PcG reference set: the “writer” 
(E(z)) and the “reader” (Pc) of the H3K27me mark, the only other known 
catalytic member of the PcG (dRing), and dRing’s associated factor (Psc). 
Sequence and domain information was retrieved for Drosophila, mouse, and 
human PcG proteins from the Swissprot, Uniprot, Ensembl, and SMART 
databases. In order to identify putative homologs of these proteins in other 
organisms, I performed BLAST searches using the Drosophila, mouse and 
human proteins as queries2, 3. The Blastp searches, using the NCBI web 
server (http://www.ncbi.nlm.nih.gov/BLAST) were performed at low, 
medium, and high stringencies to obtain all possible proteins in the following 
organisms: Arabidopsis thaliana, Caenorhabditis elegans (worm), 
Strongylocentrotus purpuratus (sea urchin), Danio rerio (zebrafish), Xenopus 
laevis (frog), Gallus Gallus (chicken), Canis familiaris (dog), Mus musculus 
(mouse), and Homo sapiens (human). Since homologous domains between 
my species are very well conserved, variation of BLAST parameters, such 
as gap costs and substitution matrices did not significantly alter my results. 
In addition, I developed a program (Motif Search) to query motifs less than 
15 amino acids in length such as the Pc box. Sequence similarity between 
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homologous domains and full-length sequences was used to compute a 
weighted score by multiplying a fixed weight to the BLAST score and 
computing an overall weighted sum. Key domains for PcG proteins were 
identified including: the chromodomain and Pc-box for Pc homologs, the 
RING domain for Psc and dRing homologs, and the SET and SANT domains 
for E(z) homologs. A list of putative homologs containing the highest scores 
was compiled for each class of PcG proteins, and homologs in different 
species were selected by manual inspection. Finally, the ClustalW 
program was used to cluster putative homologs to ensure that proteins with 
similar key domains with minor amino acid differences such as Ring1A and 
Ring1B were categorized correctly. In addition, a reverse BLAST of all the 
putative homologs was also performed against the Drosophila genome to 
ensure that the forward BLAST hit was accurate. Many databases of 
translated cDNA libraries are inherently incomplete, and so gene sequences 
of those PcG homologs that were found to be absent in a given organism 
were also queried against the organism’s genome. Finally, putative PcG 
homologs were mapped onto a phylogenetic tree of organisms. Additional 
potential paralogs of dPsc were found in Drosophila through my algorithm. 
These proteins are Su(z)2 and l(3)-73Ah; however as they are not well 
characterized as functional Psc homologs, these proteins have been excluded 
these proteins from my phylogenetic tree. 
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Sequence alignments were constructed using the Emboss program and 
CEC-1 was predicted as a putative Polycomb homolog because of its high 
sequence similarity with Drosophila and mouse Cbx8 chromodomains. Two 
stretches of amino acids within the N-terminus and C-terminus of CEC-1 also 
shared a strong sequence similarity with the Drosophila and mouse Cbx8 Pc 
boxes. In Figure 4.5B, the ClustalW program was used to create a multiple 
sequence alignment of Cbx proteins and subsequently fed into the PHYLIP 
software program5. The protdist and neighbor joining programs within 
PHYLIP were used to construct the Cbx paralog tree (Figure 4.5B) and the 
Emboss local alignment program was used to determine sequence similarity 
and identity percentages. 
Domain Prediction (Experimental) 
Peptide Pulldown Assay  
Extracts were made by taking frozen, lysed cells (1 g/ pull-down condition) 
and extracting them in 500cmM extraction buffer (500 mM NaCl, 20 mM 
HEPES pH 7.9, 25% glycerol, 1.5 mMcMgCl2, 0.2 mM EDTA, 1 mM PMSF, 
Complete Mini EDTA-free [Roche], 0.2% Triton X-100) for 1 hour at 4°C. 
Extracts were then diluted to 150 mM NaCl with ‘no-salt’ extraction buffer, 
mixed with 2.5 μg of biotinylated histone peptide-linked Dynabeadsc(M-280 
Streptavidin, Dynal) at the ratio of 2.5 μg /100 μL beads and nutated for 30 
minutes at 4°C. Peptide-linked Dynabeads and associated proteins were 
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then washed five times in 300 mM KCl wash buffer (300 mM KCl, 20 mM 
HEPES pH 7.9, 0.2% Triton X-100), and one time in a buffer containing 4 
mM Hepes pH 7.5 and10 mM NaCl. Peptide-bound proteins were eluted in 
boiling SDS-PAGE loading buffer, resolved on Novex 4-20% gradient gels, 
and probed with antibodies recognizing the PrA tag (DAKOP0450). Peptides 
were synthesized by Upstate Biotech (UBI) and Proteomics Resource Center 






























During my PhD, I had a chance to collaborate with a variety of groups on 
and off the Rockefeller campus. A group that I collaborated with was Dr. 
Dmitri Krainc’s group, at Harvard Medical School (Cambridge, MA). His group 
was interested in looking at human Htt (a Hungtingtin disease related 
protein), and was interested in studying PTMs on this specific protein. I 
contributed to this project by using my software tool, PredMod, to predict  
several acetylation sites on this protein. My top ranked predicted lysine was 
K444, which eventually was shown to facilitate trafficking into 
autophagosomes, and had an effect on neurodegeneration in cultured 
neurons and in mouse brain (Jeong, Then et al. 2009).  
A second collaboration that I was involved in with the lab of Dr. Elliott 
Hertzberg at Albert Einstein College of Medicine, who was involved in looking 
at a series of Connexin proteins (gap junction proteins) in rat cells. My top 
predictions aligned with their primary detected acetyl-sites in Connexin23. 
They are in now the process of conducting further experiments to determine 





Software Tools  
During my graduate studies, I developed PredMod as described in the 
computational section of my thesis. The usage of this tool is as follows:  
Usage of PredMod. After you have inserted the sequence of your protein of 
interest, press “Submit” and the following output will appear: The first 
section displays the entire sequence with each lysine colored red or blue. A 
red colored lysine indicates that the lysine is predicted as acetylated, and a 
blue colored lysine suggests that the lysine is not acetylated. Listed below 
the protein sequence are the total number of predicted acetylated lysines, 
not predicted as acetylated lysines, and a total lysine count. In the second 
section, you will see that there are two tables of proteins, one table shaded 
in yellow and one table shaded in blue.  Table columns are as follows:  
Position of lysine in protein, confidence (calculation described below), and 
the flanking sequence with the target lysine bolded. The yellow shaded list 
contains predicted acetylated lysines, and the blue shaded list lysines that 
are not predicted as acetylated. Note that the confidences are in ranked 
order. The top-most yellow shaded lysine is the lysine predicted as 
acetylated with the highest confidence.  The bottom-most blue shaded lysine 
is least likely to be acetylated.  Note that this program runs at a lower 
stringency threshold than results reported in the text (high stringency), and 
thus the output contains a higher number of positive predictions.   
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Confidence levels are calculated by the difference between the output score 
and the optimal calculated threshold. Thus, if a lysine scores above the 
designated threshold, it is predicted as an acetylated lysine. Confidence 
values range between 0.5 and 67, where 67 most likely represents an 
identical match between a histone sequence existing in the training set and 
an identical input sequence.  
 Another tool, useful for the lab was Motif Search, a software program which 
enables a user to enter any length motif, and then this motif is searched for 
in the entire proteome of all organisms. The output received is something 
like this:  
Together, PredMod along with Motif Search can potentially help the scientific 
























Table represents lysines in human histones H3, H4, H2B, H2A and their acetylation status as 
noted in literature (references are in rightmost column). Asterisk (*) represents lysines that 
were predicted by the algorithm and validated experimentally by mass spectrometry.  
 
Human Histone H3.1  (NP_003520.1) 
 
 
Lysine residue Validated as 
Acetylated 
Not Observed as 
Acetylated 
Reference(s) 
K4 X  (Zhang, Tang et 
al. 2002; Zhang 
and Tang 2003; 
Zhang, Eugeni et 
al. 2003; Garcia, 
Barber et al. 
2005; Hake, 
Garcia et al. 2006; 
Garcia, Hake et al. 
2007) 
K9 X  (Cocklin and Wang 
2003; Beck, 
Nielsen et al. 
2006) 
K14 X  (Cocklin and Wang 
2003; Beck, 
Nielsen et al. 
2006; Kim, 
Sprung et al. 
2006) 
K18 X   (Garcia, Hake et 
al. 2007),(Hake, 
Garcia et al. 
2006),(Zhang and 
Tang 2003),(Beck, 
Nielsen et al. 
2006),(Kim, 
Sprung et al. 
2006) 
K23 X  (Garcia, Hake et 
al. 2007),(Hake, 
Garcia et al. 
2006),(Zhang and 
Tang 2003),(Beck, 
Nielsen et al. 
2006),(Kim, 
Sprung et al. 
2006) 
K27 X  (Cocklin and Wang 
2003; Beck, 




K36 X  (Morris, Rao et al. 
2007) 
K37   *(sod but) 
K56  X  (Xie, Song et al. 
2009),(Das, Lucia 
et al. 2009) 
K79 X                  
(Garcia, Hake et 
al. 2007) 
K64  X  
K115  X  
K122  X  
 
Human Histone H4 (NP_003529.1) 
 
Lysine residue Validated as 
Acetylated 
Not Observed as 
Acetylated 
References 







Kim et al. 
2004) 







Kim et al. 
2004) 







Kim et al. 
2004) 









Kim et al. 
2004) 
K20  X  
K31 X  (1) 
K44  X  
K59  X  
K77  X  
K79  X  
K91  X  
 
 
Human Histone H2B.2(Q) (NP_003519.1) 
 
Lysine residue Validated  as 
Acetylated 
Not Observed as 
Acetylated 
References 
K5 X  (Beck, Nielsen et 
al. 2006),(Kim, 
Sprung et al. 
2006) 
K11 X   (Beck, Nielsen et 
al. 2006),(Kim, 
Sprung et al. 
2006) 
K12 X  (Bonenfant, Coulot 
et al. 2006) 
K15 X  (Bonenfant, Coulot 
et al. 2006) 
K16 X   (Beck, Nielsen et 
al. 2006),(Kim, 
Sprung et al. 
2006) 
K20 X  (Beck, Nielsen et 
al. 2006),(Kim, 
Sprung et al. 
2006),(Bonenfant, 
Coulot et al. 2006) 
K23 X  (Kim, 
Sprung et 
al. 2006) 
K24 X                (9) 
K37  X  
K30  X  
K34  X  
K43  X  
K46  X  
K57  X  
K85  X  
K108  X  
K116   *(sod but) 
K120  X  





Human Histone H2A.C (NP_003503.1) 
 
Lysine residue Validated as 
Acetylated 
Not observed as 
Acetylated 
References 
K5 X  (Bonenfant, Coulot 
et al. 2006) 
K9   * 
K13   * 
K15   * 
K36   X  
K75  X  
K76  X  
K95 (R)  X  
K118  X  
K119  X  
K125 (R)   * 
K127(R)   * 
K129    * 
 
Note (R) stands for reversed sequences that were used in the alignment 
H2AK125  KTESHHKAKGK  (R)KGKAKHHSETK 
H2AK125   ESHHKAKGK    (R)KGKAKHHSE 
H2AK96         NDEELNKLLGRVT  (R)TVRGLLLKNLEEDN 
 






Human pan-acetyl IP substrates  
Table includes published proteins that were immunoprecipitated with a pan-acetyl antibody 
(Kim, Sprung et al. 2006). Asterisk (*) represents lysines that were not predicted by the 















by algorithm  
(position on 





277 18  7,10,159   
HrNP  
(gi:14043070)  
372 18 350 144,145,52  
SMARCA (gi|55958983)  1570 121 1531,1533, 1535 999, 1003 , 472, 
1366, 984 
 
P29ING4 (gi|18873723)  249  28 130 129, 156, 160  127* 
CREB binding (peptide 
info only known) 
  6    





SON DNA BASS1 
(gi|5737751)  
344 26 206  144, 157, 98 117* 
HMG1 (gi|96888)  215 43  7,8,114,177 28* 




support for the 
transcript and the 
protein) 
     
EF1alpha (gi|62896589) 462 47  385, 386 318* 
PHD15 (gi|18676594) 639 39  605, 617, 604 109* 
Heat shock  90kd 
Protein 1 Beta  
(gi|34304590) 
724 75  624 148, 505 
 
 
Heat shock 27 KD 
(gi|4504517) 





539  40 20  
 
 





165  14 125  44,49,76  
Cofilin(gi|30582531)  166  25 132 164,31  
Profilin1 (gi|30582841) 140    105* 
Tropomyosin3(gi|55665
780) 
232 22  100 212* 
Actin (gi|16924319) 363 19 49   
180 
 
LMNA (gi|21619981) 465 32 418 316, 90, 180  
ANXA5(gi|12655149) 320 22 101 29, 26 , 212  
RHO gdi alpha 
(gi|30582607) 
204  19 141    
Phospholipase Cbeta 1 
(gi|9438229)  




mutase 1  
254 18  106 39   
PEST (gi|9966827) 179 22   152* 
Cyclin T1 (gi|2981196)  726 51  93,219, 356 492* 
VegF (gi|3712671) 254 21 171, 169  174, 44 176* 
B23 nucleoplasmin 
(gi|825671)  





85 11  65 
 
74* 
BCell (gi|32698936) 1494 41 36 49,275, 234  





557 70 499  410, 413, 56  
HYPK (gi|27692116) 129 9 35 87  
Rbbp7 (gi|57209887)  285 16   79, 9, 21 
 
39* 
UBL4A (gi|57284174) 180 10 48   54* 
Transkeletose 
(gi|31417921) 
457 33 66 94, 78 431* 
Aldolase A  (gi|28595) 108 7 13, 42 28   
























Literature validated human proteins.  
Table includes lysines that were reported as acetylated in literature. Asterisk (*) represents 

















lly by our 
algorithm  
(position on 
protein) at  
threshold 
* 
TFIIB (gi|135629) 290 31 238 267, 136, 14 52* 
P53(gi|23491729) 393 19 320, 370 
321,305 




Rch1 (gi:791185)   529 28 22  102, 42  
Myc (gi:71774083)  
 
439 24  317, 143, 157, 
371, 275, 323 
422,289,355  
Smad 7 (gi|18418630)   426 20 64,70  5,185  
Stat1 (gi|2507413)  749 55  679, 511 410*, 
413* 




288 26 266,273  219, 71 264* 
MyoD (gi|34862)  319 11 102 133 99*, 
104* 
HIV-tat (gi:114842145)  101 13  53, 12  50* 
Alpha-Tubulin (gi|55977864 
) 
451 19  60, 338, 112 40* 
ACTR (gi:2707770) 
 
1412 55  691, 316 , 87 630*, 
629* 
HMG14(Chen, Lin et al. 
1999) (gi:184251)  
216 43 11 , 2 8, 87 , 172  
CDK9 (gi|8099630)  372 29 44  24, 272, 178 48* 
P65 (gi|5689767) 
 
551 17  123, 343 221*  
HMG-A1 (gi|123377|)  107 16 65, 67,71 55, 15   
Stat3  ( gi|48429227) 770 47 685 631, 548, 153  
ANDR (gi|113830) 919 39 630,632,633 299,316, 590  
Esr1 (gi|544257)  595 28 299 401,266 302*, 
303* 
Gata3 (gi|120962) 443 21 302  250, 159, 
254 
305* 
P73 (gi:2370177)  500 17 331, 321 346, 138, 
157, 192 
327* 




Beta catenin (gi|860988)  781 26 49 270,672 345* 
HIF-1 (gi|4504385)  826 49  297, 159, 629  532* 
SATB1 (gi|417747) 763 44 136 241, 11, 518, 
129 
 
FOX01   
(gi|116241368) 
655 25 245, 248, 265 272, 354, 179  
INAR2  (gi|1352466) 515 21  180, 182, 243 399* 
HSP90alpha  (gi|92090606) 732 80  277, 513, 276 294* 
Ku70  (gi|125729) 609 59  253,249,358 539*, 
542* 
PGRC1   
(gi|6647589) 





HTT (gi|1170192) 3144 278 444 178,1168,92,
410,700 
 





































Literature validated human proteins and the references of 
acetylation sites. 
 
Protein  References 
TFIIB (Imhof, Yang et al. 1997) 
HMG-A1 (Munshi, Merika et al. 1998) 
P53 (Gu and Roeder 1997) 
Gata1 (Boyes, Byfield et al. 1998) 
Rch1  (Bannister, Miska et al. 2000) 
HMG-14 (Bergel, Herrera et al. 2000) 
C-Myb (Tomita, Towatari et al. 2000) 
E2F1 (Martinez-Balbas, Bauer et al. 2000) 
C-myc  (Zhang, Faiola et al. 2005) 
Smad7 (Simonsson, Heldin et al. 2005) 
Stat1  (Kramer, Baus et al. 2006) 
HIV1-integrase (Kiernan, Vanhulle et al. 1999) 
MyoD (Polesskaya, Duquet et al. 2000) 
HIV-tat (Dormeyer, Dorr et al. 2003) 
ACTR (Chen, Lin et al. 1999) 
CDK9 (Fu, Yoon et al. 2007) 
P65 (Ishinaga, Jono et al. 2007) 
SATB1 (Pavan Kumar, Purbey et al. 2006) 
STAT3 (Glozak, Sengupta et al. 2005) 
HMGB-1 (Glozak, Sengupta et al. 2005) 
Beta-catenin  (Wolf, Rodova et al. 2002; Levy, Wei 
et al. 2004) 
Alpha-tubulin  (Glozak, Sengupta et al. 2005) 
GATA3 (33) 
P73 (33) 
SMC3 (Zhang, Shi et al. 2008) 
HIF-1 (Jeong, Bae et al. 2002) 
RB (Markham, Munro et al. 2006) 





Fox01 (Greer and Brunet 2005) 
PGC1 (35) 
INF (35) 
AR (Fu, Wang et al. 2004) 
HTT (Jeong, Then et al. 2009) 
CDT1 (Glozak and Seto 2009) 












































P-values in Chapter 2 
To test whether the observed enrichment of small residues (G/A), K, S was 
statistically significant in the histone and nonhistone datasets, I determined 
the frequency of these same residues flanking a lysine in the entire human 
proteome. I employed the hypergeometric test to measure the statistical 
relevance of this observation (STable 4). “LIT” represents those lysines 
validated in literature, “HIST” represents lysines in histones, and “PAN” 
represents pan-acetyl antibody substrate lysines. Top row shows the 
position of the residue with respect to the target lysine (position 0, not 
shown). List below the table displays the values for each of the variables in 
the hypergeometric distribution: all lysines in the human proteome = N; 
number of times the particular residue is seen flanking in each position in 
human proteome= K; total number of lysines in each independent 
validation dataset = n; number of times particular residue is seen flanking 
in each position in validation dataset = m. 
 
 -6 -5 -4 -3 -2 -1 1 2 3 4 5 6 
small             
LIT 0.0
04 




































             
K             
LIT 0.0
6 
0.7 0.03 0.13 0.36 0.6 0.01 0.3 0.0
2 












0.11 0.07 0.7 0.0
1 
0.3 0.16 0.007 0.02 
             
S             
LIT 0.3
9 
0.12 0.005 0.05 0.12 0.09 0.99 0.8 0.1
5 
0.3 0.5 0.8 
HIST 0.4
5 
0.5 0.2 0.8 0.8 1 0.01 0.9 0.3 0.8 0.5 0.46 
PAN 0.2 0.4 0.04 0.11 0.11 0.6 0.09 0.8 0.0
7 




N in human dataset = 5127294 
 
K in each position for small, serine, and lysine residues dataset 
containing all human lysines. 
 
Position 0: GA:535591  S:291208  K:389280 
Position 1: GA:621026  S:315489  K:323314 
Position 2: GA:677578  S:307757  K:416567 
Position 3: GA:663899  S:312774  K:468003 
Position 4: GA:632418  S:310841  K:537247 
Position 5: GA:584283  S:289536  K:486015 
Position 7: GA:597697  S:296377  K:486758 
Position 8: GA:610849  S:404638  K:537885 
Position 9: GA:593694  S:362154  K:462707 
Position 10: GA:586526  S:336826  K:418813 
Position 11: GA:591499  S:303442  K:325808 
Position 12: GA:531503  S:292427  K:387452 
 
 
m in each position for small, serine, and lysine residues: Human 
Histone Dataset 
Position 0: GA:7  S:2  K:3    
Position 1: GA:8  S:2  K:5    
Position 2: GA:3  S:3  K:9    
Position 3: GA:16  S:1  K:2    
Position 4: GA:10  S:1  K:3    
Position 5: GA:12  S:0  K:3    
Position 7: GA:12  S:5  K:3    
Position 8: GA:8  S:1  K:3    
Position 9: GA:9  S:3  K:3    
Position 10: GA:4  S:1  K:13    
Position 11:  GA:5  S:2  K:4    
Position 12:  GA:9  S:2  K:2    
 
m in each position for small, serine, and lysine residues: Pan-acetyl 
(PA) Dataset 
Position 0: GA:10  S:5  K:12    
Position 1: GA:11  S:4  K:11    
Position 2: GA:8  S:7  K:6    
Position 3: GA:11  S:6  K:11    
Position 4: GA:12  S:3  K:9    
Position 5: GA:17  S:6  K:9    
Position 7: GA:11  S:6  K:4    
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Position 8: GA:5  S:3  K:12    
Position 9: GA:9  S:7  K:6    
Position 10: GA:9  S:6  K:7    
Position 11: GA:11  S:5  K:9    
Position 12: GA:5  S:5  K:9    
 
m in each position for small, serine, and lysine residues: Literature 
(Lit) Dataset 
Position 0: GA:13  S:4  K:8    
Position 1: GA:7  S:6  K:3    
Position 2: GA:4  S:9  K:9    
Position 3: GA:9  S:7  K:8    
Position 4: GA:16  S:6  K:7    
Position 5: GA:14  S:6  K:5    
Position 6: GA:0  S:0  K:57    
Position 7: GA:8  S:2  K:11    
Position 8: GA:8  S:7  K:7    
Position 9: GA:8  S:5  K:10    
Position 10: GA:7  S:4  K:6    
Position 11: GA:14  S:2  K:6    
Position 12: GA:6  S:13  K:6    
 









S. cerevisiae chromatin-associated protein predictions  
yEAF7   
Predictions: K27, K343, K165, K142 
 
ySPT6  
Predictions: K958, K491, K494, K118, K120, K319 
 
ySir3  
Predictions: K52, K436, K445,K3,K827 
 
 
Sodium butyrate (10mM) treated samples  
Additional acetylation sites detected: 
H2A:  K95, K119 
H2B: K34, K46, K108, K116 
















































Appendix Figures  
 
Appendix Figure 1: Enlarged tree from Figure 2.3.  









Appendix Figure 2. Experimental Mass Spectrometry validation in human cells  
A. CAD (Collisionally Activated Dissociation) mass spectrum of the [M+2H]2+ histone H2A 4-11 
peptide. Shown is a mixture of two single-acetylated species with the same sequence but with 
different sites of acetylation. The MS/MS data indicate acetylation on K5 and K9. The amino acid 
sequence is shown above the spectrum, and the masses associated with the sequence 
correspond to the expected b- and y-type fragment ions for the propionylated H2A 4-11 peptide. 
The masses of the observed b- and y-type fragment ions are assigned to their corresponding m/z 
peaks in the spectrum and are also underlined with the sequence. The asterisks denote fragment 
ions that are shifted lower in mass by 14 amu, indicating the presence of in vivo singly-
acetylated species. For this analysis, histone H2A was purified from HL60 cells, lysines were 
derivatized with propionic anhydride, and H2A peptides were generated with trypsin. H2A 
peptides were gradient-eluted via nanoflow-HPLC and mass analyzed with an LTQ-FT mass 
spectrometer.  
B. CAD mass spectrum of the [M+2H]2+ histone H2A 12-17 peptide. Shown is a mixed spectrum 
of two single-acetylated species with the same sequence but with different sites of acetylation. 
The MS/MS data indicate acetylation on K13 and K15. The amino acid sequence is shown above 
the spectrum, and the masses associated with the sequence correspond to the expected b- and 
y-type fragment ions for the propionylated H2A 12-17 peptide. The masses of the observed b- 
and y-type fragment ions are assigned as in (A). For this analysis, histone H2A was purified, 
derivatized, trypsin digested, and gradient-eluted as in C.  CAD mass spectrum of the [M+2H]2+ 
histone H2A 122-129 peptide. Shown is is a mixed spectrum of three mono-acetylated species 
with the same sequence but with different sites of acetylation. The MS/MS data indicate 
acetylation on K125, K127, and K129. The amino acid sequence is shown above the spectrum, 
and the masses associated with the sequence correspond to the expected singly-charged b- and 
y-type fragment ions for the fully deutero-acetylated H2A 122-129 peptide. The masses of the 
observed b- and y-type fragment ions are assigned to their corresponding m/z peaks in the 
spectrum and are also underlined with the sequence. The asterisks denote fragment ions that are 
shifted lower in mass by 3 amu, indicating the presence of in vivo (non-deutero) mono-
acetylated species. For this analysis, histone H2A was purified from HL60 cells, digested with 
GluC, derivatized with deutero succinimido acetate to increase hydrophobicity of the 122-129 
H2A peptide, and H2A peptides were gradient-eluted via nanoflow-HPLC and mass analyzed with 
an LTQ Orbitrap mass spectrometer. To obtain this spectrum, the precursor ion, m/z 534.1, was 
targeted for isolation with a 3 amu window and fragmented via CAD. Image and text provided by 
















Appendix Figure 3. MS validation of acetylation sites in budding yeast proteins 
Eaf7, Sir3, and Spt6.  
Identification of lysine acetylated peptides in Eaf7,Sir3,and Spt6 by LC/MS/MS. The labels b 
and y designate the N- and C-terminal fragments, respectively, of the peptide produced by 
breakage at the peptide bond in the mass spectrometer. The number represents the 
number of N- or C-terminal residues present in the peptide fragment. The superscripts 0, ∗ 
mean water or ammonia loss, respectively 
A.Eaf7K343 
B.Sir3K3 
C.Spt6K319, Spt6K773, Spt6K958, and Spt6K1238  




















    
 
Appendix Figure 4 MS validation of acetylation sites in WT and A15K mutant strain  
 
LC/MS/MS spectra displaying H3K9ac and H3K14 ac. Figures supplied by Ben Garcia 
displaying the WT (H3K9-17) peptide and H3A15K (H3K9-17) spectrum. (Images and data 
provided by Ben Garcia, Princeton University (Princeton, NJ). H3K36 methylation data under 
A15K mutation and G13V mass spectra image is presently unavailable, but quantitative data 
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